<SEC-DOCUMENT>0001040130-23-000040.txt : 20230620
<SEC-HEADER>0001040130-23-000040.hdr.sgml : 20230620
<ACCEPTANCE-DATETIME>20230620103459
ACCESSION NUMBER:		0001040130-23-000040
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20230615
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230620
DATE AS OF CHANGE:		20230620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28827
		FILM NUMBER:		231023850

	BUSINESS ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
		BUSINESS PHONE:		(561) 426-4444

	MAIL ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pets-20230615.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:0995af87-8441-4a17-9983-cd5ba40a2d1c,g:3ff95010-c02b-4337-b1d5-48a25c9c26fe,d:ba2bd5aaf37a4e7e94cdc66ddede8954--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pets-20230615</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF80L2ZyYWc6OGZkNmY1M2Q0MTU4NGJlZjk5NGUzOTQ4ZTFmM2RhZTQvdGFibGU6MDlmYjkyNmJlZDYwNDMwMDk3MTU1Y2JkMTFlNGQ0YjUvdGFibGVyYW5nZTowOWZiOTI2YmVkNjA0MzAwOTcxNTVjYmQxMWU0ZDRiNV8xLTEtMS0xLTYwNTI2_7196e62e-0a78-4eb6-8882-31a94b2970a2">0001040130</ix:nonNumeric><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF80L2ZyYWc6OGZkNmY1M2Q0MTU4NGJlZjk5NGUzOTQ4ZTFmM2RhZTQvdGFibGU6MDlmYjkyNmJlZDYwNDMwMDk3MTU1Y2JkMTFlNGQ0YjUvdGFibGVyYW5nZTowOWZiOTI2YmVkNjA0MzAwOTcxNTVjYmQxMWU0ZDRiNV8yLTEtMS0xLTYwNTI2_61ba15f3-7736-4a1d-a8dc-107bda1892c4">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pets-20230615.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-16</xbrli:startDate><xbrli:endDate>2023-05-16</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iba2bd5aaf37a4e7e94cdc66ddede8954_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzU5_16c580aa-843c-4e48-910d-6f89fc570697">8-K</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzYw_ef3f44dd-74b9-4fdc-868e-bf82c134e156">June 15, 2023</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzYy_3c774c2c-cfb7-4f78-bceb-0c85dfb1cdc3">PetMed Express, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:31.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.832%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6MTI1NzMzYzU5OWE0NDNkNThiOWFhZmRhNmIzMjA3YjEvdGFibGVyYW5nZToxMjU3MzNjNTk5YTQ0M2Q1OGI5YWFmZGE2YjMyMDdiMV8wLTAtMS0xLTYwNTI2_5f12460f-5513-4d45-85af-2258d956b4da">Florida</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6MTI1NzMzYzU5OWE0NDNkNThiOWFhZmRhNmIzMjA3YjEvdGFibGVyYW5nZToxMjU3MzNjNTk5YTQ0M2Q1OGI5YWFmZGE2YjMyMDdiMV8wLTItMS0xLTYwNTI2_0f6c9a57-e958-4c33-b1aa-f9336912c0ce">000-28827</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6MTI1NzMzYzU5OWE0NDNkNThiOWFhZmRhNmIzMjA3YjEvdGFibGVyYW5nZToxMjU3MzNjNTk5YTQ0M2Q1OGI5YWFmZGE2YjMyMDdiMV8wLTQtMS0xLTYwNTI2_0d3bc073-2532-4662-b71c-f983d8bfbb68">65-0680967</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzY1_28a942d0-d621-41c0-87aa-f5bf26c3d510">420 South Congress Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzY2_f1f3477b-6579-42b8-a647-e71addc3bb9d">Delray Beach</ix:nonNumeric>, <ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzYz_687b9918-bccb-418a-a020-67f06f37fe91">Florida</ix:nonNumeric> <ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzY3_357837cd-ae6d-44e2-a91b-f8fa98143f04">33445</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF80MjM_56fafcfa-fd4d-49db-88a3-c8264a33aae3">561</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzU3_14123da4-cc26-46f8-b475-399ea40f61ee">526-4444</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NDc2YTRhODZkMmRiNDZjZmIzOWNjZjg2YTRiODEyMjAvdGFibGVyYW5nZTo0NzZhNGE4NmQyZGI0NmNmYjM5Y2NmODZhNGI4MTIyMF8wLTAtMS0xLTYwNTI2_9d6e331a-dba5-49ad-9323-128d44ca5e40">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NDc2YTRhODZkMmRiNDZjZmIzOWNjZjg2YTRiODEyMjAvdGFibGVyYW5nZTo0NzZhNGE4NmQyZGI0NmNmYjM5Y2NmODZhNGI4MTIyMF8yLTAtMS0xLTYwNTI2_371715d8-822e-4c37-ab7c-e6feace8380b">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NDc2YTRhODZkMmRiNDZjZmIzOWNjZjg2YTRiODEyMjAvdGFibGVyYW5nZTo0NzZhNGE4NmQyZGI0NmNmYjM5Y2NmODZhNGI4MTIyMF80LTAtMS0xLTYwNTI2_186f5b24-d48e-4212-9526-b5272885f758">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NDc2YTRhODZkMmRiNDZjZmIzOWNjZjg2YTRiODEyMjAvdGFibGVyYW5nZTo0NzZhNGE4NmQyZGI0NmNmYjM5Y2NmODZhNGI4MTIyMF82LTAtMS0xLTYwNTI2_d67178c2-b702-40d2-998d-a7215cd2e351">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NGRiN2U5ZWM2YTJkNDIyOWFhYmI0YmQ5NGY3YzVkZDUvdGFibGVyYW5nZTo0ZGI3ZTllYzZhMmQ0MjI5YWFiYjRiZDk0ZjdjNWRkNV8xLTAtMS0xLTYwNTI2_56d58696-aab8-4f40-a115-4838f0ab400a">Common Stock, par value $.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NGRiN2U5ZWM2YTJkNDIyOWFhYmI0YmQ5NGY3YzVkZDUvdGFibGVyYW5nZTo0ZGI3ZTllYzZhMmQ0MjI5YWFiYjRiZDk0ZjdjNWRkNV8xLTEtMS0xLTYwNTI2_629e7028-c523-4aac-bd95-6b48f168620a">PETS</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NGRiN2U5ZWM2YTJkNDIyOWFhYmI0YmQ5NGY3YzVkZDUvdGFibGVyYW5nZTo0ZGI3ZTllYzZhMmQ0MjI5YWFiYjRiZDk0ZjdjNWRkNV8xLTItMS0xLTYwNTI2_4cdb63f0-80fa-4eaa-81b4-cfcc9525dec8">NASDAQ</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzU4_0315b95d-8d62-4219-8206-a3f5f0c4c5b0">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div><div id="iba2bd5aaf37a4e7e94cdc66ddede8954_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 15, 2023, the Board of Directors (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) of PetMed Express, Inc. (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) took the following actions relating to the Company&#8217;s equity plans and executive compensation programs:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Amendment and Restatement of 2022 Employee Equity Compensation Restricted Stock Plan</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">              The Board approved an amendment to the Company&#8217;s 2022 Employee Equity Compensation Restricted Stock Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Original 2022 Employee Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) to add the ability to grant restricted stock units (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) and performance stock units (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) under such plan and to make other related ministerial changes.  Such amendment was effected through the amendment and restatement of the plan and the related renaming of the plan as the &#8220;2022 Employee Equity Compensation Plan&#8221; (as amended and restated, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Amended 2022 Employee Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;). </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">              The Original 2022 Employee Plan permitted the Company to make grants of shares of its common stock, par value $0.001 per share (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), that are subject to a risk of forfeiture or restrictions on transfer, or both, which lapse upon a specified period of service and/or upon the satisfaction of performance conditions (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Restricted Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).   Shares of Restricted Stock are considered outstanding for dividend, voting, and other purposes from and after the grant date thereof even though they may be subject to forfeiture based on vesting or other conditions.  In contrast, RSUs and PSUs represent an obligation to issue shares of Common Stock in the future only after the satisfaction of applicable vesting and/or performance conditions.  As set forth in the Amended 2022 Employee Plan, RSUs represent the right to receive a share of Common Stock for each RSU, or a cash payment the value of which is equal to the fair market value of one share of Common Stock, in each case upon completion of a period of service or satisfaction of other conditions (subject to any applicable deferral election that may be authorized by the Company).  PSUs represent the right to receive a share of Common Stock for each PSU, or a cash payment the value of which is equal to the fair market value of one share of Common Stock, in each case upon achievement of performance goals (subject to any applicable deferral election that may be authorized by the Company).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">              The Amended 2022 Employee Plan amended and restated the Original 2022 Employee Plan to allow the Company to issue RSUs and  PSUs, which were not expressly authorized by the Original 2022 Employee Plan.  Other than the adding the authority to issue RSUs and PSUs and related ministerial changes, the Amended 2022 Employee Plan does not make any material changes to the Original 2022 Employee Plan.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">              In connection with adopting and approving the Amended 2022 Employee Plan, on June 15, 2023, the Board also adopted a form of award agreement pursuant to which RSUs may be granted under the Amended 2022 Employee Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Employee RSU Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) and a form of award agreement pursuant to which PSUs may be granted under the Amended 2022 Employee Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Employee PSU Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).  The forms of Employee RSU Agreement and Employee PSU Agreement contain usual and customary provisions for vesting, delivery of shares, and taxes and withholding, among other provisions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">              The foregoing descriptions of the Amended 2022 Employee Plan, the form of Employee RSU Agreement, and the form of Employee PSU Agreement are not complete and are qualified in its entirety by reference to the copies of such documents attached to this Current Report on Form 8-K as Exhibits 10.1, 10.3, and 10.4, respectively, as well as to a copy of the Amended 2022 Employee Plan attached as Exhibit 10.2 hereto marked to show the amendments made to the Original 2022 Employee Plan.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Amendment and Restatement of 2015 Outside Director Equity Compensation Restricted Stock Plan</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">              Also on June 15, 2023, the Board approved an amendment to the Company&#8217;s 2015 Outside Director Equity Compensation Restricted Stock Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Original 2015 Director Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) to add the ability to grant RSUs under such plan and to make other ministerial changes.  Such amendment was effected through the amendment and restatement of the Original 2015 Director Plan and the related renaming of such plan as the &#8220;2015 Outside Director Equity Compensation Plan&#8221; (as amended and restated, the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Amended 2015 Director Plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;). Other than the adding the authority to issue RSUs and related ministerial changes, the Amended 2015 Director Plan does not make any material changes to the Original 2015 Director Plan.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with adopting and approving the Amended 2015 Director Plan, on June 15, 2023, the Board also adopted a form of award agreement pursuant to which RSUs may be granted under the Amended 2015 Director  Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Director RSU Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;).  The form of Director RSU Agreement contains usual and customary provisions for vesting, delivery of shares, and taxes, among other provisions.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">              The foregoing descriptions of the Amended 2015 Director Plan and the form of Director RSU Agreement are not complete and are qualified in its entirety by reference to the copies of such documents attached to this Current Report on Form 8-K as Exhibits 10.5 and 10.7, respectively, as well as to a copy of the Amended 2015 Director Plan attached as Exhibit 10.6 hereto marked to show the amendments made to the Original 2015 Director Plan.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Award of RSUs and PSUs to CFO under Amended 2022 Employee Plan</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">              Upon the recommendation of the Compensation Committee of the Board, on June 15, 2023, Christine Chambers, the Company&#8217;s Chief Financial Officer, was granted 11,750 RSUs under the Amended 2022 Employee Plan (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Chambers RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;), of which 3,750 of the Chambers RSUs were awarded in recognition of Ms. Chambers&#8217; contributions during fiscal year 2023 and the remaining 8,000 awarded as a part of the equity award cycle for fiscal year 2024.  One-third of the Chambers RSUs will vest on each of the first three anniversaries of the date of grant, subject to Ms. Chambers&#8217; continued employment with the Company through the applicable vesting date, with any unvested RSUs being forfeited upon Ms. Chambers ceasing to be an employee of the Company, with certain exceptions (such as death and disability).  Notwithstanding the foregoing, in the event that Ms. Chambers resigns for &#8220;Good Reason&#8221; (as defined in the RSU award agreement) following a &#8220;Change of Control&#8221; (as defined in the Amended 2022 Employee Plan) or is terminated without cause prior to the vesting of the RSUs, a pro rata portion of the unvested RSUs that would have otherwise vested such year will become vested upon termination.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">              Also on June 15, 2023, Ms. Chambers was awarded 8,000 PSUs.  Ms. Chambers will earn shares of Common Stock pursuant to such PSUs based on the Company&#8217;s total shareholder return (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">TSR</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) relative to the S&amp;P 600 Specialty Retail Index (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Index</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) over an overall three-year performance period consisting of the 2024 through 2026 fiscal years, as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9679;     100% of the target number of shares, which is 8,000 shares, will be earned if the Company&#8217;s TSR is equal to or greater than the 75th percentile of the Index (the &#8220;maximum target payout&#8221;);</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9679;     50% of the target number of shares, which is 4,000 shares, will be earned if the Company&#8217;s TSR is equal to at least the 50th percentile of the Index;  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9679;     25% of the target number of shares, which is 2,000 shares, will be earned if the Company&#8217;s TSR is equal to at least the 25th percentile of the Index (the &#8220;minimum threshold&#8221;);</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9679;     No shares will be earned if the TSR is less than the 25th percentile of the Index, and the payout is capped at 2,000 shares if absolute TSR is negative, regardless of relative position to the Index; and</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#9679;     Linear scaling will be used to determine the number of shares earned for performance between the maximum target payout level and minimum threshold payout level.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">With certain exceptions (such as death and disability), the PSUs awarded to Ms. Chambers will be forfeited if Ms. Chambers ceases to be employed before the end of the performance period.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Approval of NEO Annual Incentive Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon the recommendation of the Compensation Committee of the Board, on June 15, 2023, the Board adopted an Annual Incentive Plan, or AIP, that is designed to reward the Company&#8217;s Chief Executive Officer (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">CEO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) and Chief Financial Officer (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">CFO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221;) with a cash bonus for meeting or exceeding financial and other performance goals during a particular fiscal year (beginning with fiscal year 2024).  Under the AIP, for each fiscal year, the Compensation Committee of the Board will establish a target bonus opportunity for both the CEO and CFO that is equal to the percentage of such person&#8217;s base salary that he or she will receive as a cash bonus if the AIP performance goals are achieved at target.  However, the actual bonus received may be higher or lower depending on the Company&#8217;s level of achievement of the AIP financial performance goals.  For the 2024 fiscal year, the Board, upon the recommendation of the Compensation Committee, established a bonus target opportunity of 100% of base salary for the CEO and 50% of base salary for the CFO, with payout amounts being weighted 40% on achievement of a pre-established revenue target and 60% on achievement of a pre-established adjusted EBITDA target.  The threshold bonus amount for the CEO and CFO is 50% of the target bonus, and the maximum bonus amount is 200% of target for the CEO and 150% of target for the CFO.    </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3</span></div></div></div><div id="iba2bd5aaf37a4e7e94cdc66ddede8954_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(d)&#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.173%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Description</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="a8k06152023-ex101.htm">PetMed</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%;text-decoration:underline" href="a8k06152023-ex101.htm"> Express, Inc. 2022 Employee Equity Compensation Plan (as amended and restated)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a8k06152023-ex102.htm">PetMed Express, Inc. 2022 Employee Equity Compensation Plan (as amended and restated), marked to show amendments made to the 2022 Employee Equity Compensation Restricted Stock Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a8k061523-ex103.htm">Form of Restricted Stock Unit Agreement under 2022 Employee Equity Compensation Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a8k061523-ex104.htm">Form of Performance Stock Unit Agreement under 2022 Employee Equity Compensation Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a8k06152023-ex105.htm">PetMed Express, Inc. 2015 Outside Director Equity Compensation Plan (as amended and restated)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a8k06152023-ex106.htm">PetMed Express, Inc. 2015 Outside Director Equity Compensation Plan (as amended and restated), marked to show amendments made to the 2015 Outside Director Equity Compensation Restricted Stock Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="a8k06152023-ex107.htm">Form of Restricted Stock Unit Agreement under 2015 Outside Director Equity Compensation Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as Inline XBRL)</span></div></td></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*  *  *</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4</span></div></div></div><div id="iba2bd5aaf37a4e7e94cdc66ddede8954_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: June&#160;20, 2023</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.416%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PETMED EXPRESS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">/s/ Christine Chambers</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Christine Chambers</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Financial Officer and Treasurer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a8k06152023-ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3729d74d1de94bf3a0763d20ccac975d_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:360pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">  Exhibit 10.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 EMPLOYEE EQUITY COMPENSATION PLAN</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amending and restating the PetMed Express, Inc. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Employee Equity Compensation Restricted Stock Plan)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1. PURPOSE OF PLAN</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The purpose of the PetMed Express, Inc. 2022 Employee Equity Compensation Plan f&#47;k&#47;a the 2022 Employee Equity Compensation Restricted Stock Plan (the &#34;2022 Plan&#34;), which is being established by PetMed Express, Inc. on behalf of itself, its subsidiaries and affiliates (collectively, the &#34;Company&#34;), is to secure and retain employees of outstanding ability and to provide additional motivation to such employees to exert their best efforts on behalf of the Company. The Company expects that it will benefit from the added commitment which such employees will have in the welfare of the Company as a result of their ownership or increased ownership of the Company's Common Stock.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2. STOCK SUBJECT TO THE 2022 PLAN&#59; TYPES OF AWARDS</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The shares that may be awarded under the 2022 Plan (without payment by participants) shall be the common stock, par value $.001 per share, of the Company (&#8220;Common Stock&#8221;), and shall be authorized, but un-issued, shares. The maximum number of shares of Common Stock that may be awarded hereunder (subject to any adjustments as provided below) shall not in the aggregate exceed 1,000,000 shares. Shares of Common Stock forfeited as a result of a participant's termination of employment or other conditions of the award not being met shall again become available for award under the 2022 Plan.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following types of awards may be granted under the 2022 Plan&#58;</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">Restricted Stock, which means shares of Common Stock that are subject to a risk of forfeiture or restrictions on transfer, or both a risk of forfeiture and restrictions on transfer, which may lapse upon the completion of a period of service or satisfaction of other conditions (which may include the achievement of performance goals established by the Committee).</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Restricted Stock Units, which means the right to receive a share of Common Stock for each Restricted Stock Unit, or a cash payment the value of which is equal to the fair market value of one share of Common Stock, in each case upon completion of a period of service or satisfaction of other conditions (subject to any applicable deferral election that may be authorized by the Company).</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">Performance Stock Units, which means the right to receive a share of Common Stock for each Performance Stock Unit, or a cash payment the value of which is equal to the fair market value of one share of Common Stock, in each case upon achievement of performance goals (subject to any applicable deferral election that may be authorized by the Company).  Performance Stock Units may condition the right to receive a share of Common Stock on the completion of a period of service in addition to the achievement of performance goals.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3. ADMINISTRATION</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2022 Plan shall be administered by the Compensation Committee of the Board of Directors, each of whom is a &#34;non-employee director&#34; as defined in Rule 16b-3 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended (the &#34;Committee&#34;). No member of the Committee shall be eligible to participate in the 2022 Plan.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Committee shall have the sole authority to (i) make grants of awards under the 2022 Plan&#59; (ii) consistent with the 2022 Plan, determine the terms and conditions of each award&#59; (iii) interpret the 2022 Plan and the instruments evidencing awards granted under the 2022 Plan&#59; (iv) adopt, amend and rescind rules and regulations for the administration of the 2022 Plan&#59; and (v) generally administer the 2022 Plan and make all determinations in connection therewith which may be necessary or advisable, and all such actions of the Committee shall be binding upon all participants. Committee decisions and selections shall be made by a majority of its members present at the meeting at which a quorum is present, and shall be final. Any decision or selection reduced to writing and signed by all of the members of the Committee, including through electronic consent, shall be as fully effective as if it had been made at a meeting duly held.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4. ELIGIBILITY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All employees, including officers, of the Company who are, from time to time, responsible for the management, growth and protection of the business of the Company shall be eligible for awards under the 2022 Plan. No member of the Board of Directors of the Company shall be eligible to participate in the 2022 Plan unless such director is also an employee of the Company. The employees who shall receive awards under the 2022 Plan shall be selected from time to time by the Committee in its sole discretion, from among those eligible, and the Committee shall determine, in its sole discretion, the type of award to grant such employee and the number of shares (or cash compensation) that may be paid with respect to each award. The Committee may, within the terms of the 2022 Plan, be selective and non-uniform with respect to its determination of the amount of awards, type of awards and the eligible employees to whom such awards are made.&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a condition to the grant of an award under the 2022 Plan, each eligible employee selected to participate shall execute and deliver to the Company, including through electronic medium, an agreement evidencing the award, in form and substance satisfactory to the Committee, reflecting the conditions and restrictions imposed upon the award..</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.911%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5. TERMS OF RESTRICTED STOCK AWARDS </font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">Rights with respect to Shares.  A participant to whom an award of Restricted Stock has been made under the 2022 Plan will have all of the rights of a stockholder with respect to the shares of Common Stock so awarded, including, but not limited to, the right to receive, subject to the following sentence, such cash dividends, if any, as may be declared on such shares from time to time and the right to vote (in person or by proxy) such shares at any meeting of the Company&#8217;s stockholders. As a condition to the grant of the award under the 2022 Plan, and without limiting the provisions of Section 5(c) hereof, dividends, if any, as may be declared on such shares of Common Stock shall be deposited into an escrow or similarly segregated account, and disbursement of such dividends to the participant will occur only upon the delivery of the shares of Common Stock to which such dividends relate, and in the event the shares of Common Stock to which such dividends relate are forfeited, the participant&#8217;s right to receive disbursement of such dividends will be forfeited and the amount of the dividends shall be returned to the Company.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Terms, Conditions and Restrictions. In addition to such other terms, conditions, restrictions, and performance goals as may be imposed by the Committee and contained in the instrument under which awards of Restricted Stock are made pursuant to the 2022 Plan, (i) no Restricted Stock so awarded shall be restricted for a period (the &#34;Restriction Period&#34;) of less than one year or more than ten years unless otherwise specified by the Committee&#59; and (ii) except as provided in paragraph (e) below, the recipient of the award shall remain in the employ of the Company during the Restriction Period or otherwise forfeit all right, title and interest in and to the shares subject to such restrictions.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">Transferability Restriction. No share awarded under the 2022 Plan shall be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of during the Restriction Period applicable thereto.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Certificates&#59; Stock Legend. Shares of Restricted Stock granted under the 2022 Plan shall be evidenced by certificates or book entries in the books of the Company (or, as applicable, its transfer agent). Certificates or book entries evidencing shares of Restricted Stock shall be registered in the name of the participant, shall include an appropriate legend referring to the terms, conditions, and restrictions applicable to such shares and the Company may, in its sole discretion, retain physical possession of the certificate in escrow until all restrictions have been lifted or requirements met.  </font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">Lapse of Restrictions. The restrictions imposed under paragraph (a) above shall terminate with respect to the shares of Common Stock to which they apply on the earliest to occur of the following, unless otherwise specified by the Committee&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the expiration of the Restriction Period and, if applicable, the satisfaction of any performance goals specified in the applicable award agreement&#59;</font></div></td></tr></table></div><div style="padding-left:18pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the participant's total and permanent Disability (as defined below)&#59; or</font></td></tr></table></div><div style="padding-left:18pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.141%"><tr><td style="width:1.0%"></td><td style="width:5.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the participant's death.</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Disability&#8221; means the employee&#8217;s inability to substantially perform his or her duties in his or her normal and regular manner, with reasonable accommodation, for more than ninety (90) days (whether consecutive or not) in any twelve (12) month period, as evidenced by a certificate signed either by a physician mutually acceptable to the Company and employee or, if the parties cannot agree, by a physician selected by agreement of a physician designated by the Company and a physician designated by the employee.  Employee shall submit to a reasonable number of examinations by the physician making the determination of Disability, and employee hereby authorizes the disclosure and release of all supporting medical records to the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates or book entries evidencing shares of Common Stock with respect to which restrictions have lapsed as provided above shall, upon lapse thereof, be released from escrow and delivered to the participant or, in the event of participant's death, to participant's personal representative. Any stock legend referring to the restrictions imposed hereunder shall thereupon be removed.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6. TERMS OF RESTRICTED STOCK UNITS AND PERFORMANCE STOCK UNITS</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">Terms and Conditions. Subject to the terms of this 2022 Plan, the Committee will determine all terms and conditions of each award of Restricted Stock Units and Performance Stock Units, including but not limited to&#58; (i) the number of Shares to which such Award relates&#59; (ii) for Performance Stock Units, the performance goals that must be achieved to earn the award, during such period as the Committee specifies&#59; (iii)&#160;the length of the vesting or performance period and, if different, the date on which payment of the benefit provided under the award will be made&#59; and (iv) whether to settle such awards in cash, in shares, or in a combination of cash and shares.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Performance Goals.  The performance goals for Performance Stock Units may include, but are not limited to, the performance of the Company or any one or more of its subsidiaries, affiliates or its or their business units (or any combination thereof) with respect to the following measures&#58; net income&#59;, operating income&#59; pretax earnings&#59; earnings per share&#59; share price, including growth measures and total stockholder return&#59; earnings before interest and taxes and related margin&#59; earnings before interest, taxes, depreciation and&#47;or amortization and related margin&#59; sales or revenue growth, whether in general, by type of product, application or service, or by type of customer&#59; gross or operating profit or margins&#59; cash flow, and any combination of any of the foregoing business criteria.  Performance goals may also relate to an employee&#8217;s individual performance.  </font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Committee reserves the right to adjust performance goals, or modify the manner of measuring or evaluating a performance goal, for any reason it determines is appropriate, including but not limited to&#58; (i) by excluding the effects of charges for reorganizing and restructuring&#59; discontinued operations&#59; asset write-downs&#59; gains or losses on the disposition of a business&#59; or mergers, acquisitions or dispositions&#59; and extraordinary, unusual and&#47;or non-recurring items of gain or loss&#59; (ii) excluding the costs of litigation, claims, judgments or settlements&#59; (iii) excluding the effects of changes laws, regulations, or accounting principles&#59; and (iv) excluding any accruals of amounts related to payments under the 2022 Plan or any other compensation arrangement maintained by the Company or an affiliate.  </font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">No Stockholder Rights&#59; Dividend Equivalents.  Holders of Restricted Stock Units and Performance Stock Units shall not have any rights as stockholders of the Company with respect to such awards (including no voting rights or rights to receive dividends) unless and until shares of Common Stock are issued upon settlement of such awards.  However, the Committee may, in its discretion, provide holders of Restricted Stock Units and Performance Stock Units with the right to receive payment equal to the amount of dividends they would have received if their units had instead been outstanding shares, and such dividend equivalents will either, at the discretion of the Committee, be (i) accumulated and paid, in cash or shares in the Committee&#8217;s discretion, at the same time and to the same extent that the underlying Restricted Stock Unit or Performance Stock Unit award vests or (ii) reinvested in additional units that are subject to the same terms and conditions (including vesting and forfeiture) as the Restricted Stock Unit or Performance Stock Unit award to which the dividend equivalent relates.  For clarity, in no event will an employee receive a dividend equivalent payment unless, until and to the same extent as the underlying Restricted Stock Unit or Performance Stock Unit award vests and is paid.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7. TERMS APPLICABLE TO ALL AWARDS</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">Investment Representation.  If the shares of Common Stock that have been awarded to an employee pursuant to the terms of the 2022 Plan are not registered under the Securities Act of 1933, as amended, pursuant to an exemption from registration, such employee, if the Committee shall deem it advisable, may be required to represent and agree by written or electronic instrument (i) that any shares of Common Stock acquired by such employee pursuant to the 2022 Plan will not be sold except pursuant to an effective registration statement under the Securities Act of 1933, as amended, or pursuant to an exemption from registration under such Act, and (ii) that such employee has acquired such shares of Common Stock for the participant&#8217;s own account and not with a view to the distribution thereof.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Change of Control of the Company. Upon the occurrence of a Change of Control, unless otherwise provided in an award agreement or specifically prohibited under applicable laws or by the rules and regulations of any governing governmental agencies or national securities exchanges, or unless the Committee shall determine otherwise before the Change of Control, any Restriction Period and restrictions imposed on Restricted Stock shall terminate, and all Restricted Stock Units and Performance Stock Units shall immediately vest (assuming, with respect to Performance Stock Units for which the performance period has not expired as of the Change of Control date, that the target performance goals have been met) and be settled in accordance with the terms of the award agreement, in all cases as of immediately prior to the occurrence of the Change of Control.</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of the 2022 Plan, a &#34;Change of Control&#34; of the Company shall be deemed to have occurred if&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) any person, as such term is used in Sections 13(d)(3) and 14(d)(2) of the Securities Exchange Act of 1934, as amended, becomes a beneficial owner (within the meaning of Rule 13d-3 under such Act) of 20% or more of the Company's outstanding Common Stock&#59;</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)  within any 24 month period, the persons who were directors of the Company immediately before the beginning of such period (the &#8220;Incumbent Directors&#8221;) shall cease (for any reason other than death) to constitute at least a majority of the Board or the board of directors of any successor to the Company, provided that any director who was not a director at the beginning of such period shall be deemed to be an Incumbent Director if such director (A) was elected to the Board by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually or by prior operation of this Section 7(b)(ii), and (B) was not designated by a person who has entered into an agreement with the Company to effect a transaction described in Section 7(b)(iii)&#59; or</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii) the Company is merged, consolidated or reorganized into or with, or sells all or substantially all of its assets to, another company or other entity, and immediately after such transaction less than 80% of the voting power of the then-outstanding securities of such company or other entity immediately after such transaction is held in the aggregate by holders of the Company's Common Stock immediately before such transaction.</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, if the Company enters into an agreement or series of agreements or the Board of Directors of the Company adopts a resolution which results in the occurrence of any of the foregoing events, and the employment of a participant is terminated after and as the sole result of the entering into of such agreement or series of agreements or the adoption of such resolution then, upon the occurrence of any of the events described above, a Change of Control shall be deemed to have retroactively occurred on the date of entering into of the earliest of such agreements or the adoption of such resolution and the participants shall be entitled to the delivery as of such date of any forfeited Restricted Stock and payment with respect to any previously forfeited Restricted Stock Units or Performance Stock Units as though such employee were employed on the date of the Change of Control. </font></div><div style="padding-left:18pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt">Withholding. The Company shall have the right to deduct from payments of any kind due to the participant (whether due hereunder or otherwise), any federal, state or local taxes of any kind or any other amounts required by law to be withheld with respect to the grant, vesting, or settlement of an award.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt">Additional Conditions. In the agreements evidencing awards or otherwise, the Committee may impose such other and additional terms, conditions and restrictions upon the award as it, in its discretion, deems appropriate.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8. MISCELLANEOUS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) No Right to Receive Award. Nothing in the 2022 Plan shall be construed to give any employee of the Company any right to receive an award under the 2022 Plan.</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Adjustments. If (i) the Company shall at any time be involved in a merger or other transaction in which the shares of Common Stock are changed or exchanged, (ii) the Company shall subdivide or combine the shares of Common Stock or the Company shall declare a stock dividend, (iii) the Company shall effect a cash dividend the amount of which, on a per share basis, exceeds ten percent (10%) of the fair market value of a share at the time the dividend is declared, or the Company shall effect any other dividend or other distribution in the form of cash, or a repurchase of shares, that the Board of Directors determines by resolution is special or extraordinary in nature or that is in connection with a transaction that the Company characterizes publicly as a recapitalization or reorganization involving the shares&#59; or (iv) any other event shall occur, which, in the case of this clause (iv), in the judgment of the Committee necessitates an adjustment to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this 2022 Plan, then the Company shall, in such manner as it may deem equitable to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this 2022 Plan, adjust any or all of&#160;the number and type of shares subject to this 2022 Plan under Section 2, the number and type of shares subject to outstanding awards, and the performance goals of an award. In any such case, the Committee may also (or in lieu of the foregoing) make provision for a cash payment to the holder of an outstanding award in exchange for the cancellation of all or a portion of the award (without the consent of the holder of an award) in an amount determined by the Committee.</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any shares of Common Stock or other securities of the Company received by an employee as a stock dividend on, or as a result of stock splits, combinations, exchanges of shares, reorganizations, mergers, consolidations or otherwise with respect to shares of Restricted Stock shall have the same status, be subject to the same restrictions and bear the same legend, if any, as the shares received pursuant to the original award.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) No Effect on Employment Rights. Nothing in the 2022 Plan or in the instruments evidencing the grant of an award hereunder shall in any manner be construed to limit in any way the right of the Company or a subsidiary to terminate an employee's employment at any time, or give any right to an employee to remain employed by the Company.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.911%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:13.5pt;text-indent:-13.5pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-align:right;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d) Governing Law. All provisions of the 2022 Plan shall be construed in accordance with the laws of Florida except to the extent preempted by federal law.</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e) No Restriction on Corporate Action. Nothing contained in the 2022 Plan shall be construed to prevent the Company or any subsidiary from taking any corporate action that is deemed by the Company or such subsidiary to be appropriate or in the best interest, whether or not such action would have an adverse effect on the 2022 Plan or any shares of Common Stock granted under the 2022 Plan. No employee, non-employee director, beneficiary or other person shall have any claim against the Company or any subsidiary as a result of any such action.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9. EFFECTIVE DATE OF 2022 PLAN</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2022 Plan originally became effective on July 28, 2022, which is the date on which is was approved by the Shareholders of the Company.&#160; This 2022 Plan is an amendment and restatement of the originally adopted plan, and such amendment and restatement was adopted and approved by the Board of Directors of the Company on June ____, 2023.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10. AMENDMENTS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Committee may amend or terminate the 2022 Plan without shareholder approval unless shareholder approval is required by any federal or state law or regulation or the rules of The Nasdaq Stock Market. The Committee shall not have the right to amend the 2022 Plan to&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">except as provided in paragraph 8(b) of the 2022 Plan, increase the maximum number of shares reserved for purposes of the 2022 Plan&#59;</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">extend the duration of the 2022 Plan&#59; or</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">materially increase the benefits accruing to participants under the 2022 Plan.</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any amendment or alteration to the 2022 Plan which impairs the rights of any participant with respect to an outstanding award is not effective unless written or electronic consent from the participant is obtained.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Committee may modify, amend or cancel any award granted under the 2022 Plan&#59; provided that, except as otherwise expressly provided in the 2022 Plan or the award agreement, any modification or amendment that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">materially diminishes the rights of a participant in the 2022 Plan or the cancellation of an award shall be effective only if agreed to by the participant, but the Committee need not obtain participant consent for the modification, amendment or cancellation of an award as follows&#58; (A) to the extent the Committee deems such action necessary to comply with any applicable law or the listing requirements of any principal securities exchange or market on which the Company&#8217;s shares are then traded&#59; (B) to the extent the Committee deems necessary to preserve favorable accounting or tax treatment of any award for the Company&#59; or (C) to the extent the Committee determines that such action does not materially and adversely affect the value of an award or that such action is in the best interest of the affected participant (or any other person(s) as may then have an interest. Notwithstanding the foregoing, unless determined otherwise by the Committee, any such amendment shall be made in a manner that will enable an award intended to be exempt from Code Section 409A (as defined below) to continue to be so exempt, or to enable an award intended to comply with Code Section 409A to continue to so comply.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11. DURATION AND TERMINATION</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This 2022 Plan shall terminate on, and no further awards may be granted hereunder after, July 28, 2032. In addition, the Committee may terminate the 2022 Plan at any time prior thereto. The termination of this 2022 Plan shall not, however, affect the validity or terms and conditions of any award properly granted hereunder before the date of termination.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12. COMPLIANCE WITH SECTION 16(B) AND CODE SECTION 409A</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2022 Plan is intended to comply with all applicable conditions of Rule 16b-3 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended. All transactions involving the Company's executive officers are subject to such conditions, regardless of whether the conditions are expressly set forth in the 2022 Plan. Any provision of the 2022 Plan that is contrary to a condition of Rule 16b-3 shall not apply to executive officers of the Company.  Any award granted under the 2022 Plan shall be provided or made in such manner and at such time as to either make the award exempt from, or comply with, the provisions of Section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Code Section 409A&#8221;), to avoid a plan failure described in Code Section 409A, and the provisions of Code Section 409A are incorporated into the 2022 Plan to the extent necessary for any award that is subject to Code Section 409A to comply therewith.  For purposes of an award that is subject to Code Section 409A, if a participant&#8217;s termination of employment or service triggers the payment of compensation under such award, then the participant will be deemed to have terminated employment or service upon his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A. Notwithstanding any other provision in the 2022 Plan or an award to the contrary, if any participant is a &#8220;specified employee&#8221; within the meaning of Code Section 409A as of the date of his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A, then, to the extent required to avoid the imposition of additional taxes under Code Section 409A, any payment made to the participant on account of such separation from service shall not be made before a date that is six months after the date of the separation from service.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>a8k06152023-ex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie4984d415cbf4966a4bdf3560123f859_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:360pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PETMED EXPRESS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 EMPLOYEE EQUITY COMPENSATION</font></div><div style="text-align:center"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">RESTRICTED STOCK </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> PLAN</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(amending and restating the PetMed Express, Inc. </font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2022 Employee Equity Compensation Restricted Stock Plan)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1. PURPOSE OF PLAN</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The purpose of the PetMed Express, Inc. 2022 </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Employee Equity Compensation Plan f&#47;k&#47;a the 2022 Employee Equity Compensation </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Plan (the &#34;2022 Plan&#34;), which is being established by PetMed Express, Inc. on behalf of itself, its subsidiaries and affiliates (collectively, the &#34;Company&#34;), is to secure and retain employees of outstanding ability and to provide additional motivation to such employees to exert their best efforts on behalf of the Company. The Company expects that it will benefit from the added commitment which such employees will have in the welfare of the Company as a result of their ownership or increased ownership of the Company's Common Stock.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2. STOCK SUBJECT TO THE 2022 PLAN</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#59; TYPES OF AWARDS</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The shares that may be awarded under the 2022 Plan (without payment by participants) shall be the common stock, par value $.001 per share, of the Company (&#8220;Common Stock&#8221;), and shall be authorized, but un-issued, shares. The maximum number of shares of Common Stock that may be awarded hereunder (subject to any adjustments as provided below) shall not in the aggregate exceed 1,000,000 shares. Shares of Common Stock forfeited as a result of a participant's termination of employment </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or other conditions of the award not being met </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shall again become available for award under the 2022 Plan.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The following types of awards may be granted under the 2022 Plan&#58;</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt;text-decoration:underline">Restricted Stock, which means shares of Common Stock that are subject to a risk of forfeiture or restrictions on transfer, or both a risk of forfeiture and restrictions on transfer, which may lapse upon the completion of a period of service or satisfaction of other conditions (which may include the achievement of performance goals established by the Committee).</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt;text-decoration:underline">Restricted Stock Units, which means the right to receive a share of Common Stock for each Restricted Stock Unit, or a cash payment the value of which is equal to the fair market value of one share of Common Stock, in each case upon completion of a period of service or satisfaction of other conditions (subject to any applicable deferral election that may be authorized by the Company).</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt;text-decoration:underline">Performance Stock Units, which means the right to receive a share of Common Stock for each Performance Stock Unit, or a cash payment the value of which is equal to the fair market value of one share of Common Stock, in each case upon achievement of performance goals (subject to any applicable deferral election that may be authorized by the Company).  Performance Stock Units may condition the right to receive a share of Common Stock on the completion of a period of service in addition to the achievement of performance goals.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3. ADMINISTRATION</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2022 Plan shall be administered by the Compensation Committee of the Board of Directors, each of whom is a &#34;non-employee director&#34; as defined in Rule 16b-3 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended (the &#34;Committee&#34;). No member of the Committee shall be eligible to participate in the 2022 Plan.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Committee shall have the sole authority to (i) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">award shares of Common Stock (&#8220;Restricted Stock&#8221;)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">make grants of awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> under the 2022 Plan&#59; (ii) consistent with the 2022 Plan, determine the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">provisions of the shares to be awarded, the restrictions and other </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">terms and conditions </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">applicable to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> each award</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through"> of shares under the 2022 Plan&#59;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (iii) interpret the 2022 Plan</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> the instruments evidencing </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">the restrictions imposed upon stock awarded under the 2022 Plan and the shares awarded</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">awards granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> under the 2022 Plan&#59; (iv) adopt, amend and rescind rules and regulations for the administration of the 2022 Plan&#59; and (v) generally administer the 2022 Plan and make all determinations in connection therewith which may be necessary or advisable, and all such actions of the Committee shall be binding upon all participants. Committee decisions and selections shall be made by a majority of its members present at the meeting at which a quorum is present, and shall be final. Any decision or selection reduced to writing and signed by all of the members of the Committee, including through electronic consent, shall be as fully effective as if it had been made at a meeting duly held.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4. ELIGIBILITY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All employees, including officers, of the Company who are, from time to time, responsible for the management, growth and protection of the business of the Company shall be eligible for awards </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">of stock </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">under the 2022 Plan. No member of the Board of Directors of the Company shall be eligible to participate in the 2022 Plan unless such director is also an employee of the Company. The employees who shall receive awards under the 2022 Plan shall be selected from time to time by the Committee in its sole discretion, from among those eligible, and the Committee shall determine, in its sole discretion, the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">type of award to grant such employee and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">number of shares </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">to be awarded to each such employee selected</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(or cash compensation) that may be paid with respect to each award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The Committee may, within the terms of the 2022 Plan, be selective and non-uniform with respect to its determination of the amount of awards</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, type of awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and the eligible employees to whom such awards are made.&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">As a condition to the grant of an award </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">under the 2022 Plan</font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, each eligible employee selected to participate shall execute and deliver to the Company, including through electronic medium, an agreement evidencing the award, in form and substance satisfactory to the Committee</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">reflecting the conditions and restrictions imposed upon the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">award..</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.911%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5. </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">RIGHTS WITH RESPECT TO SHARES</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TERMS OF RESTRICTED STOCK AWARDS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt;text-decoration:underline">Rights with respect to Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A participant to whom an award of Restricted Stock has been made under the 2022 Plan will have all of the rights of a stockholder with respect to the shares of Common Stock so awarded, including, but not limited to, the right to receive, subject to the following sentence, such cash dividends, if any, as may be declared on such shares from time to time and the right to vote (in person or by proxy) such shares at any meeting of the Company&#8217;s stockholders. As a condition to the grant of the award under the 2022 Plan, and without limiting the provisions of Section </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">7</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">b</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) hereof, dividends, if any, as may be declared on such shares of Common Stock shall be deposited into an escrow or similarly segregated account, and disbursement of such dividends to the participant will occur only upon the delivery of the shares of Common Stock to which such dividends relate, and in the event the shares of Common Stock to which such dividends relate are forfeited, the participant&#8217;s right to receive disbursement of such dividends will be forfeited and the amount of the dividends shall be returned to the Company.</font></div><div><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">6. INVESTMENT REPRESENTATION</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">If the shares of Common Stock that have been awarded to an employee pursuant to the terms of the 2022 Plan are not registered under the Securities Act of 1933, as amended, pursuant to an exemption from registration, such employee, if the Committee shall deem it advisable, may be required to represent and agree by written or electronic instrument (i) that any shares of Common Stock acquired by such employee pursuant to the 2022 Plan will not be sold except pursuant to an effective registration statement under the Securities Act of 1933, as amended, or pursuant to an exemption from registration under such Act, and (ii) that such employee has acquired such shares of Common Stock for the participant&#8217;s own account and not with a view to the distribution thereof.</font></div><div><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">7. RESTRICTIONS</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt;text-decoration:line-through">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terms, Conditions and Restrictions. In addition to such other terms, conditions</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through"> and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> restrictions</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, and performance goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> as may be imposed by the Committee and contained in the instrument under which awards of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Common</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Stock are made pursuant to the 2022 Plan, (i) no </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Common</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Stock so awarded shall be restricted for a period (the &#34;Restriction Period&#34;) of less than one year or more than ten years unless otherwise specified by the Committee&#59; and (ii) except as provided in paragraph (e) below, the recipient of the award shall remain in the employ of the Company during the Restriction Period or otherwise forfeit all right, title and interest in and to the shares subject to such restrictions.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt;text-decoration:line-through">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transferability Restriction. No share awarded under the 2022 Plan shall be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of during the Restriction Period applicable thereto.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(d)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt;text-decoration:line-through">(c) Agreements</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#59; Stock Legend. </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">As a condition to the grant of an award</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Shares of Restricted Stock granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> under the 2022 Plan</font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">, each eligible employee selected to participate shall execute and deliver to the Company, including through electronic medium, an agreement evidencing the award, in form and substance satisfactory to the Committee reflecting the conditions and restrictions imposed upon the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Restricted Stock awarded</font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> shall be evidenced by certificates or book entries in the books of the Company (or, as applicable, its transfer agent)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. Certificates or book entries evidencing shares of Restricted Stock </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">pursuant to such awards will</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">shall be registered in the name of the participant, shall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> include an appropriate legend referring to the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">terms, conditions, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">restrictions </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">and the instruments to which such awards are subject.</font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">applicable to such shares and the Company may, in its sole discretion, retain physical possession of the certificate in escrow until all restrictions have been lifted or requirements met.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(d) </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Additional Conditions. In the agreements evidencing awards or otherwise, the Committee may impose such other and additional terms, conditions and restrictions upon the award as it, in its discretion, deems appropriate </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">including, without limitation, that the </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Company shall have the right to deduct from payments of any kind due to the participant, any federal, state or local taxes of any kind required by law to be withheld with respect to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">shares awarded.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(e)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt;text-decoration:line-through">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapse of Restrictions. The restrictions imposed under paragraph (a) above shall terminate with respect to the shares of Common Stock to which they apply on the earliest to occur of the following, unless otherwise specified by the Committee&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the expiration of the Restriction Period</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> and, if applicable, the satisfaction of any performance goals specified in the applicable award agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#59;</font></div></td></tr></table></div><div style="padding-left:18pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the participant's total and permanent Disability (as defined below)&#59; or</font></td></tr></table></div><div style="padding-left:18pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the participant's death.</font></td></tr><tr><td colspan="3" style="background-color:#ffdead;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;</font></td><td colspan="3" style="background-color:#ffdead;padding:0 1pt"></td><td colspan="3" style="background-color:#ffdead;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Disability&#8221; means the employee&#8217;s inability to substantially perform his or her duties in his or her normal and regular manner, with reasonable accommodation, for more than ninety (90) days (whether consecutive or not) in any twelve (12) month period, as evidenced by a certificate signed either by a physician mutually acceptable to the Company and employee or, if the parties cannot agree, by a physician selected by agreement of a physician designated by the Company and a physician designated by the employee.  Employee shall submit to a reasonable number of examinations by the physician making the determination of Disability, and employee hereby authorizes the disclosure and release of all supporting medical records to the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates or book entries evidencing shares of Common Stock with respect to which restrictions have lapsed as provided above shall, upon lapse thereof, be released from escrow and delivered to the participant or, in the event of participant's death, to participant's personal representative. Any stock legend referring to the restrictions imposed hereunder shall thereupon be removed.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6. TERMS OF RESTRICTED STOCK UNITS AND PERFORMANCE STOCK UNITS</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt;text-decoration:underline">Terms and Conditions. Subject to the terms of this 2022 Plan, the Committee will determine all terms and conditions of each award of Restricted Stock Units and Performance Stock Units, including but not limited to&#58; (i) the number of Shares to which such Award relates&#59; (ii) for Performance Stock Units, the performance goals that must be achieved to earn the award, during such period as the Committee specifies&#59; (iii)&#160;the length of the vesting or performance period and, if different, the date on which payment of the benefit provided under the award will be made&#59; and (iv) whether to settle such awards in cash, in shares, or in a combination of cash and shares.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt;text-decoration:underline">Performance Goals.  The performance goals for Performance Stock Units may include, but are not limited to, the performance of the Company or any one or more of its subsidiaries, affiliates or its or their business units (or any combination thereof) with respect to the following measures&#58; net income&#59;, operating income&#59; pretax earnings&#59; earnings per share&#59; share price, including growth measures and total stockholder return&#59; earnings before interest and taxes and related margin&#59; earnings before interest, taxes, depreciation and&#47;or amortization and related margin&#59; sales or revenue growth, whether in general, by type of product, application or service, or by type of customer&#59; gross or operating profit or margins&#59; cash flow, and any combination of any of the foregoing business criteria.  Performance goals may also relate to an employee&#8217;s individual performance.  </font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Committee reserves the right to adjust performance goals, or modify the manner of measuring or evaluating a performance goal, for any reason it determines is appropriate, including but not limited to&#58; (i) by excluding the effects of charges for reorganizing and restructuring&#59; discontinued operations&#59; asset write-downs&#59; gains or losses on the disposition of a business&#59; or mergers, acquisitions or dispositions&#59; and extraordinary, unusual and&#47;or non-recurring items of gain or loss&#59; (ii) excluding the costs of litigation, claims, judgments or settlements&#59; (iii) excluding the effects of changes laws, regulations, or accounting principles&#59; and (iv) excluding any accruals of amounts related to payments under the 2022 Plan or any other compensation arrangement maintained by the Company or an affiliate.  </font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt;text-decoration:underline">No Stockholder Rights&#59; Dividend Equivalents.  Holders of Restricted Stock Units and Performance Stock Units shall not have any rights as stockholders of the Company with respect to such awards (including no voting rights or rights to receive dividends) unless and until shares of Common Stock are issued upon settlement of such awards.  However, the Committee may, in its discretion, provide holders of Restricted Stock Units and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Stock Units with the right to receive payment equal to the amount of dividends they would have received if their units had instead been outstanding shares, and such dividend equivalents will either, at the discretion of the Committee, be (i) accumulated and paid, in cash or shares in the Committee&#8217;s discretion, at the same time and to the same extent that the underlying Restricted Stock Unit or Performance Stock Unit award vests or (ii) reinvested in additional units that are subject to the same terms and conditions (including vesting and forfeiture) as the Restricted Stock Unit or Performance Stock Unit award to which the dividend equivalent relates.  For clarity, in no event will an employee receive a dividend equivalent payment unless, until and to the same extent as the underlying Restricted Stock Unit or Performance Stock Unit award vests and is paid.</font></div><div style="margin-bottom:10pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">7. TERMS APPLICABLE TO ALL AWARDS</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt;text-decoration:underline">Investment Representation.  </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">If the shares of Common Stock that have been awarded to an employee pursuant to the terms of the 2022 Plan are not registered under the Securities Act of 1933, as amended, pursuant to an exemption from registration, such employee, if the Committee shall deem it advisable, may be required to represent and agree by written or electronic instrument (i) that any shares of Common Stock acquired by such employee pursuant to the 2022 Plan will not be sold except pursuant to an effective registration statement under the Securities Act of 1933, as amended, or pursuant to an exemption from registration under such Act, and (ii) that such employee has acquired such shares of Common Stock for the participant&#8217;s own account and not with a view to the distribution thereof.</font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt;text-decoration:line-through">(f) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change of Control of the Company. Upon the occurrence of a Change of Control, unless otherwise </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">provided in an award agreement or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">specifically prohibited under applicable laws or by the rules and regulations of any governing governmental agencies or national securities exchanges, or unless the Committee shall determine otherwise</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> before the Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, any Restriction Period and restrictions imposed on Restricted Stock shall terminate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, and all Restricted Stock Units and Performance Stock Units shall immediately vest (assuming, with respect to Performance Stock Units for which the performance period has not expired as of the Change of Control date, that the target performance goals have been met) and be settled in accordance with the terms of the award agreement, in all cases as of immediately prior to the occurrence of the Change of Control.</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of the 2022 Plan, a &#34;Change </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Control&#34; of the Company shall be deemed to have occurred if&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) any person, as such term is used in Sections 13(d)(3) and 14(d)(2) of the Securities Exchange Act of 1934, as amended, becomes a beneficial owner (within the meaning of Rule 13d-3 under such Act) of 20% or more of the Company's outstanding Common Stock&#59;</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)  within any 24 month period, the persons who were directors of the Company immediately before the beginning of such period (the &#8220;Incumbent Directors&#8221;) shall cease (for any reason other than death) to constitute at least a majority of the Board or the board of directors of any successor to the Company, provided that any director who was not a director at the beginning of such period shall be deemed to be an Incumbent Director if such director (A) was elected to the Board by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually or by prior operation of this Section 7(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">f</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)(ii), and (B) was not designated by a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Person</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> who has entered into an agreement with the Company to effect a transaction described in Section 7(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">f</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)(iii)&#59; or</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii) the Company is merged, consolidated or reorganized into or with, or sells all or substantially all of its assets to, another company or other entity, and immediately after such transaction less than 80% of the voting power of the then-outstanding securities of such company or other entity immediately after such transaction is held in the aggregate by holders of the Company's Common Stock immediately before such transaction.</font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, if the Company enters into an agreement or series of agreements or the Board of Directors of the Company adopts a resolution which results in the occurrence of any of the foregoing events, and the employment of a participant is terminated after and as the sole result of the entering into of such agreement or series of agreements or the adoption of such resolution then, upon the occurrence of any of the events described above, a Change </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Control shall be deemed to have retroactively occurred on the date of entering into of the earliest of such agreements or the adoption of such resolution and the participants shall be entitled to the delivery as of such date of any forfeited Restricted Stock</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> and payment with respect to any previously forfeited Restricted Stock Units or Performance Stock Units as though such employee were employed on the date of the Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:18pt;text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.91pt;text-decoration:underline">Withholding. The </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Company shall have the right to deduct from payments of any kind due to the participant </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(whether due hereunder or otherwise)</font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, any federal, state or local taxes of any kind </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or any other amounts </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">required by law to be withheld with respect to the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">grant, vesting, or settlement of an award.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(d)</font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:6.34pt;text-decoration:underline">Additional Conditions. In the agreements evidencing awards or otherwise, the Committee may impose such other and additional terms, conditions and restrictions upon the award as it, in its discretion, deems appropriate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8. MISCELLANEOUS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) No Right to Receive Award. Nothing in the 2022 Plan shall be construed to give any employee of the Company any right to receive an award under the 2022 Plan.</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b) Adjustments. If (i) the Company shall at any time be involved in a merger or other transaction in which the shares of Common Stock are changed or exchanged, (ii) the Company shall subdivide or combine the shares of Common Stock or the Company shall declare a stock dividend, (iii) the Company shall effect a cash dividend the amount of which, on a per share basis, exceeds ten percent (10%) of the fair market value of a share at the time the dividend is declared, or the Company shall effect any other dividend or other distribution in the form of cash, or a repurchase of shares, that the Board of Directors determines by resolution is special or extraordinary in nature or that is in connection with a transaction that the Company characterizes publicly as a recapitalization or reorganization involving the shares&#59; or (iv) any other event shall occur, which, in the case of this clause (iv), in the judgment of the Committee necessitates an adjustment to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this 2022 Plan, then the Company shall, in such manner as it may deem equitable to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this 2022 Plan, adjust any or all of&#160;the number and type of shares subject to this 2022 Plan under Section 2, the number and type of shares subject to outstanding awards, and the performance goals of an award. In any such case, the Committee may also (or in lieu of the foregoing) make provision for a cash payment to the holder of an outstanding award in exchange for the cancellation of all or a portion of the award (without the consent of the holder of an award) in an amount determined by the Committee.</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font><br></font></div><div style="padding-left:13.5pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(b) Additional Shares Received With Respect to Restricted Stock. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any shares of Common Stock or other securities of the Company received by an employee as a stock dividend on, or as a result of stock splits, combinations, exchanges of shares, reorganizations, mergers, consolidations or otherwise with respect to shares of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Common Stock received pursuant to an award hereunder</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> shall have the same status, be subject to the same restrictions and bear the same legend, if any, as the shares received pursuant to the original award.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(c)&#160;Certificates or book entries evidencing Shares</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:line-through">.</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;Shares of Restricted Stock granted under the 2022 Plan </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">shall be evidenced by certificates or book entries </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">evidencing such shares </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">in the books of the Company (or, as applicable, its transfer agent)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">. Certificates or book entries evidencing shares of Restricted Stock shall be registered in the name of the participant, shall include an appropriate legend referring to the terms, conditions, and restrictions </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">applicable to such shares and the Company may, in its sole discretion, retain physical possession of the certificate in escrow until all restrictions have been lifted or requirements met.</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">d</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) No Effect on Employment Rights. Nothing in the 2022 Plan or in the instruments evidencing the grant of an award hereunder shall in any manner be construed to limit in any way the right of the Company or a subsidiary to terminate an employee's employment at any time, or give any right to an employee to remain employed by the Company.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.911%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:13.5pt;text-indent:-13.5pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-align:right;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div></td></tr></table></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">e</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) Governing Law. All provisions of the 2022 Plan shall be construed in accordance with the laws of Florida except to the extent preempted by federal law.</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">f</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) No Restriction on Corporate Action. Nothing contained in the 2022 Plan shall be construed to prevent the Company or any subsidiary from taking any corporate action that is deemed by the Company or such subsidiary to be appropriate or in the best interest, whether or not such action would have an adverse effect on the 2022 Plan or any shares of Common Stock granted under the 2022 Plan. No employee, non-employee director, beneficiary or other person shall have any claim against the Company or any subsidiary as a result of any such action.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9. EFFECTIVE DATE OF 2022 PLAN</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2022 Plan </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">shall become</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">originally became</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> effective </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">when</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">on July 28, 2022, which is the date on which is was</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> approved by the Shareholders of the Company.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160; This 2022 Plan is an amendment and restatement of the originally adopted plan, and such amendment and restatement was adopted and approved by the Board of Directors of the Company on June ____, 2023.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10. AMENDMENTS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Committee may amend or terminate the 2022 Plan without shareholder approval unless shareholder approval is required by any federal or state law or regulation or the rules of The Nasdaq Stock Market. The Committee shall not have the right to amend the 2022 Plan to&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">i</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">except as provided in paragraph 8(b) of the 2022 Plan, increase the maximum number of shares reserved for purposes of the 2022 Plan&#59;</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">ii</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">extend the duration of the 2022 Plan&#59; or</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">iii</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">materially increase the benefits accruing to participants under the 2022 Plan.</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any amendment or alteration </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">to the 2022 Plan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">which impairs the rights of any participant </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">during the Restriction Period</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">with respect to an outstanding award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> is not effective unless written or electronic consent from the participant is obtained.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Committee may modify, amend or cancel any award granted under the 2022 Plan&#59; provided that, except as otherwise expressly provided in the 2022 Plan or the award agreement, any modification or amendment that materially diminishes the rights of a participant in the 2022 Plan or the cancellation of an award shall be effective only if agreed to by the participant, but the Committee need not obtain participant consent for the modification, amendment or cancellation of an award as follows&#58; (A) to the extent the Committee deems such action necessary to comply with any applicable law or the listing requirements of any principal securities exchange or market on which the Company&#8217;s shares are then traded&#59; (B) to the extent the Committee deems necessary to preserve favorable accounting or tax treatment of any award for the Company&#59; or (C) to the extent the Committee determines that such action does not materially and adversely affect the value of an award or that such action is in the best interest of the affected participant (or any other person(s) as may then have an interest. Notwithstanding the foregoing, unless determined otherwise by the Committee, any such amendment shall be made in a manner that will enable an award intended to be exempt from Code Section 409A (as defined below) to continue to be so exempt, or to enable an award intended to comply with Code Section 409A to continue to so comply.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11. DURATION AND TERMINATION</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This 2022 Plan shall terminate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, and no further </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">stock shall be awarded</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">awards may be granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereunder</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> after</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> July </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">___</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, 2032. In addition, the Committee may terminate the 2022 Plan at any time prior thereto. The termination of this 2022 Plan shall not, however, affect </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">any restriction previously imposed or restricted stock awarded pursuant to this 2022 Plan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the validity or terms and conditions of any award properly granted hereunder before the date of termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12. COMPLIANCE WITH SECTION 16(B)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> AND CODE SECTION 409A</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2022 Plan is intended to comply with all applicable conditions of Rule 16b-3 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended. All transactions involving the Company's executive officers are subject to such conditions, regardless of whether the conditions are expressly set forth in the 2022 Plan. Any provision of the 2022 Plan that is contrary to a condition of Rule 16b-3 shall not apply to executive officers of the Company.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">  Any award granted under the 2022 Plan shall be provided or made in such manner and at such time as to either make the award exempt from, or comply with, the provisions of Section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Code Section 409A&#8221;), to avoid a plan failure described in Code Section 409A, and the provisions of Code Section 409A are incorporated into the 2022 Plan to the extent necessary for any award that is subject to Code Section 409A to comply therewith.  For purposes of an award that is subject to Code Section 409A, if a participant&#8217;s termination of employment or service triggers the payment of compensation under such award, then the participant will be deemed to have terminated employment or service upon his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A. Notwithstanding any other provision in the 2022 Plan or an award to the contrary, if any participant is a &#8220;specified employee&#8221; within the meaning of Code Section 409A as of the date of his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A, then, to the extent required to avoid the imposition of additional taxes under Code Section 409A, any payment made to the participant on account of such separation from service shall not be made before a date that is six months after the date of the separation from service.  </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ie4984d415cbf4966a4bdf3560123f859_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.576%"><tr><td style="width:1.0%"></td><td style="width:76.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Summary report&#58; </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Litera&#174; Change-Pro for Word 10.14.0.46 Document comparison done on 6&#47;16&#47;2023 1&#58;15&#58;13 PM</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Style name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Default Style</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Intelligent Table Comparison&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Active</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Original filename&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PetMed - 2022 Employee Equity Compensation Plan (as amended and restated) 4892-4518-2569 v.1.docx</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modified filename&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PetMed - 2022 Employee Equity Compensation Plan (as amended and restated) 4892-4518-2569 v.6.docx</font></div></td></tr><tr><td colspan="6" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Changes&#58;</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Add</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">92</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Delete</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">54</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Move From</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Move To</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Table Insert</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Table Delete</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Table moves to</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Table moves from</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Embedded Graphics (Visio, ChemDraw, Images etc.)</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Embedded Excel</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Format changes</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Total Changes&#58;</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">171</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>a8k061523-ex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i53ae1247d8f44368896971fc603890be_50"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:360pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.3</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC. 2022 EMPLOYEE EQUITY COMPENSATION PLAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">      THIS RESTRICTED STOCK UNIT AGREEMENT (&#8220;Agreement&#8221;) is made this ___ day of ____, 202_ by and between _______________ (the &#34;Participant&#34;) and PetMed Express, Inc., a Florida corporation, on behalf of itself, its subsidiaries and affiliates (collectively, the &#34;Company&#34;) pursuant to the Company's 2022 Employee Equity Compensation Plan (the &#34;2022 Plan&#34;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     WHEREAS, the Company desires to award the Participant restricted stock units representing the right to receive shares of the Company&#8217;s common stock, subject to the terms and conditions as hereinafter provided, in accordance with the provisions of the 2022 Plan, the terms of which are incorporated by reference herein, and a copy of the 2022 Plan is being provided to the Participant herewith.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     NOW THEREFORE, in consideration of the foregoing and the mutual undertakings herein contained, the parties hereto agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1. Grant of Restricted Stock Units.  In accordance with the terms of the 2022 Plan and subject to the further terms, conditions and restrictions contained in this Agreement, the Company hereby grants to the Participant _______ restricted stock units (the &#34;Restricted Stock Units&#34;), each of which represents the right to receive one share of the Company's common stock, par value $.001 per share (the &#34;Common Stock&#34;) upon vesting as described herein.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.  Adjustments.  In the event of any change in the outstanding Common Stock by reason of a stock dividend or distribution, recapitalization, merger, consolidation, split-up, combination, exchange of shares or the like, the Committee shall make equitable adjustments in the Restricted Stock Units corresponding to adjustments made by the Committee in the number and class of shares of Common Stock which may be issued under the 2022 Plan. The adjusted award shall be subject to the same terms, conditions, and restrictions as described herein. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.  No Transfer.  The Restricted Stock Units may not be sold, assigned, transferred, exchanged, pledged, hypothecated or otherwise encumbered or disposed of.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4. Vesting and Forfeiture.  (a) Except as provided in subsection (b) below or in the Plan, the Restricted Stock Units granted under this Agreement shall vest ratably on each of the below indicated dates in accordance with the schedule below, provided that the Participant is continuously employed by, or in the service of, the Company through the applicable vesting date&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:50.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.923%"><tr><td style="width:1.0%"></td><td style="width:53.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.750%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting Date(s)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) In the event that a Participant's employment with the Company terminates as a result of his or her death or Disability (as defined in the 2022 Plan), then the Restricted Stock Units shall become fully vested as of the date of the Participant&#8217;s termination.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (c)  For clarity, if the Participant&#8217;s employment with the Company terminates for any reason other than his or her death or Disability, then (except as otherwise provided in the 2022 Plan), any Restricted Stock Units that are unvested as of the date of the Participant&#8217;s termination shall be forfeited and no payment will be due thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)  Notwithstanding the terms of Section 7(b) of the Plan, the Restricted Stock Units granted under this Agreement will not vest (and the Restriction Period and restrictions imposed thereon shall not terminate) upon a Change of Control unless the Board or Committee, in connection with such Change of Control, expressly provides for the vesting of such Restricted Stock Units.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.  Settlement.  Upon vesting, the Company shall, as soon as practicable thereafter (but in no event later than the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> day of the third month following the end of the fiscal year in which vesting occurs), deliver to the Participant, or to the Participant's personal representative, a number of shares of Common Stock equal to the number of Restricted Stock Units that vested in either certificate or electronic form. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6. Shareholder Rights.  The Participant will not be deemed for any purposes to be a stockholder of the Company with respect to any of the Restricted Stock Units (including with respect to voting or dividends) unless and until a certificate for shares of Common Stock is issued upon vesting of the Restricted Stock Units. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.  Withholding Requirements.  The Company shall have the right to withhold from sums due to the Participant, or to require the Participant to remit to the Company, an amount sufficient to satisfy any Federal, state or local withholding tax requirements associated with the grant, vesting or settlement of the Restricted Stock Units.</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, upon the Participant&#8217;s request and subject to approval by the Committee, and compliance with any applicable legal conditions or restrictions, the Committee may determine in its sole discretion that Participant may satisfy Participant&#8217;s personal income tax obligation (at a percentage rate greater than the tax withholding obligation of the Company) by electing to have the Company withhold from the shares of Common Stock to be issued to Participant upon settlement of the Restricted Stock Units or pay the tax obligation of Participant from the sales proceeds pursuant to a broker-assisted &#8220;same day sale&#8221;, or &#8220;sell to cover&#8221; transaction, for that number of shares having a fair market value equal to the amount Participant elects to be withheld. For this purpose, the fair market value of the shares of Common Stock to be withheld shall be determined on the date that the amount of tax to be withheld is to be determined (the &#34;Tax Date&#34;). All elections by Participant to have shares withheld to satisfy Participant&#8217;s personal income tax withholding obligations shall be made in writing in a form acceptable to the Committee and shall be subject to the following restrictions&#58; (a)  the election must be made on or prior to the applicable Tax Date&#59; (b)  once made, the election shall be irrevocable as to the portion of the award as to which the election is made&#59; and (c)  all elections shall be subject to the consent or disapproval of the Committee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8. Effect of Employment.  Nothing contained in this Agreement shall confer upon the Participant the right to continue in the employment of the Company or affect any right which the Company may have to terminate the employment of the Participant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9. Amendment.  This Agreement may not be amended or modified except with the consent of the Committee and by a written instrument duly executed by the Participant and the Company, except as may be permitted by the Plan.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10. Binding Effect.  This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their heirs, personal representatives, successors and assigns.  Participant acknowledges receipt of a copy of the 2022 Plan, which is annexed hereto, represents that he or she is familiar with the terms and provisions thereof and accepts the award of Restricted Stock Units hereunder subject to all of the terms and conditions thereof and of this Agreement.  Participant hereby agrees to accept as binding, conclusive and final all decisions and interpretations of the Committee upon any questions arising under the 2022 Plan or this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company and the Participant have each executed and delivered this Agreement as of the date first above written.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPANY&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__________________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________&#91;name and title&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PARTICIPANT&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">___________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________&#91;name&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>a8k061523-ex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8fef03a5bd914a64ac5a937bbeec638e_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:360pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PERFORMANCE STOCK UNIT AGREEMENT PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC. 2022 EMPLOYEE EQUITY COMPENSATION PLAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">      THIS PERFORMANCE STOCK UNIT AGREEMENT (&#8220;Agreement&#8221;) is made this ___ day of ____, 202_ by and between _______________ (the &#34;Participant&#34;) and PetMed Express, Inc., a Florida corporation, on behalf of itself, its subsidiaries and affiliates (collectively, the &#34;Company&#34;) pursuant to the Company's 2022 Employee Equity Compensation Plan (the &#34;2022 Plan&#34;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     WHEREAS, the Company desires to award the Participant performance stock units representing the right to receive shares of the Company&#8217;s common stock upon the achievement of performance goals, subject to the terms and conditions as hereinafter provided, in accordance with the provisions of the 2022 Plan, the terms of which are incorporated by reference herein, and a copy of the 2022 Plan is being provided to the Participant herewith.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     NOW THEREFORE, in consideration of the foregoing and the mutual undertakings herein contained, the parties hereto agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1. Grant of Performance Stock Units.  In accordance with the terms of the 2022 Plan and subject to the further terms, conditions and restrictions contained in this Agreement, the Company hereby grants to the Participant _______ performance stock units (the &#34;Performance Stock Units&#34;), each of which represents the right to receive one share of the Company's common stock, par value $.001 per share (the &#34;Common Stock&#34;) upon vesting as described herein.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.  Adjustments.  In the event of any change in the outstanding Common Stock by reason of a stock dividend or distribution, recapitalization, merger, consolidation, split-up, combination, exchange of shares or the like, the Committee shall make equitable adjustments in the Performance Stock Units corresponding to adjustments made by the Committee in the number and class of shares of Common Stock which may be issued under the 2022 Plan. The adjusted award shall be subject to the same terms, conditions, and restrictions as described herein. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.  No Transfer.  The Performance Stock Units may not be sold, assigned, transferred, exchanged, pledged, hypothecated or otherwise encumbered or disposed of.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4. Vesting and Forfeiture.  (a) Except as provided in subsection (b) below or in the Plan, the Performance Stock Units granted under this Agreement shall vest on ____________, provided that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:38.65pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">&#91;insert performance goal&#93;&#59; and</font></div><div style="padding-left:38.65pt;text-align:justify"><font><br></font></div><div style="padding-left:38.65pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the Participant is continuously employed by, or in the service of, the Company on the vesting date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) In the event that a Participant's employment with the Company terminates as a result of his or her death or Disability (as defined in the 2022 Plan), then the Performance Stock Units shall become fully vested as of the date of the Participant&#8217;s termination.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (c)  For clarity, if the Participant&#8217;s employment with the Company terminates for any reason other than his or her death or Disability, then (except as otherwise provided in the 2022 Plan), any Performance Stock Units that are unvested as of the date of the Participant&#8217;s termination shall be forfeited and no payment will be due thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)  Notwithstanding the terms of Section 7(b) of the Plan, the Performance Stock Units granted under this Agreement will not vest upon a Change of Control unless the Board or Committee, in connection with such Change of Control, expressly provides for the vesting of such Performance Stock Units.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.  Settlement.  Upon vesting, the Company shall, as soon as practicable thereafter (but in no event later than the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> day of the third month following the end of the fiscal year in which vesting occurs), deliver to the Participant, or to the Participant's personal representative, a number of shares of Common Stock equal to the number of Restricted Stock Units that vested in either certificate or electronic form. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6. Shareholder Rights.  The Participant will not be deemed for any purposes to be a stockholder of the Company with respect to any of the Performance Stock Units (including with respect to voting or dividends) unless and until a certificate for shares of Common Stock is issued upon vesting of the Performance Stock Units.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.  Withholding Requirements.  The Company shall have the right to withhold from sums due to the Participant, or to require the Participant to remit to the Company, an amount sufficient to satisfy any Federal, state or local withholding tax requirements associated with the grant, vesting or settlement of the Performance Stock Units. In addition, upon the Participant&#8217;s request and subject to approval by the Committee, and compliance with any applicable legal conditions or restrictions, the Committee may determine in its sole discretion that Participant may satisfy Participant&#8217;s personal income tax obligation (at a percentage rate greater than the tax withholding obligation of the Company) by electing to have the Company withhold from the shares of Common Stock to be issued to Participant upon settlement of the Performance Stock Units or pay the tax obligation of Participant from the sales proceeds pursuant to a broker-assisted &#8220;same day sale&#8221;, or &#8220;sell to cover&#8221; transaction, for that number of shares having a fair market value equal to the amount Participant elects to be withheld. For this purpose, the fair market value of the shares of Common Stock to be withheld shall be determined on the date that the amount of tax to be withheld is to be determined (the &#34;Tax Date&#34;). All elections by Participant to have shares withheld to satisfy Participant&#8217;s personal income tax withholding obligations shall be made in writing in a form acceptable to the Committee and shall be subject to the following restrictions&#58; (a)  the election must be made on or prior to the applicable Tax Date&#59; (b)  once made, the election shall be irrevocable as to the portion of the award as to which the election is made&#59; and (c)  all elections shall be subject to the consent or disapproval of the Committee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8. Effect of Employment.  Nothing contained in this Agreement shall confer upon the Participant the right to continue in the employment of the Company or affect any right which the Company may have to terminate the employment of the Participant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9. Amendment.  This Agreement may not be amended or modified except with the consent of the Committee and by a written instrument duly executed by the Participant and the Company, except as may be permitted by the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10. Binding Effect.  This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their heirs, personal representatives, successors and assigns.  Participant acknowledges receipt of a copy of the 2022 Plan, which is annexed hereto, represents that he or she is familiar with the terms and provisions thereof and accepts the award of Performance Stock Units hereunder subject to all of the terms and conditions thereof and of this Agreement.  Participant hereby agrees to accept as binding, conclusive and final all decisions and interpretations of the Committee upon any questions arising under the 2022 Plan or this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company and the Participant have each executed and delivered this Agreement as of the date first above written.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPANY&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__________________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________&#91;name and title&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PARTICIPANT&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">___________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________&#91;name&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>a8k06152023-ex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7f900f6a35dd45419fc72ec71e0db5bd_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:360pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC.<br>2015 OUTSIDE DIRECTOR EQUITY COMPENSATION PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(amending and restating the PetMed Express, Inc. <br>2015 Outside Director Equity Compensation Restricted Stock Plan)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1. PURPOSE OF PLAN&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;The PetMed Express, Inc. 2015 Outside Director Equity Compensation Plan, f&#47;k&#47;a the 2015 Outside Director Equity Compensation Restricted Stock Plan (the &#8220;2015 Plan&#8221;), is established by PetMed Express, Inc. (&#8220;PetMed&#8221; or the &#8220;Company&#8221;) to attract, retain and compensate highly qualified individuals who are not employees or affiliates of PetMed or any of its subsidiaries, to serve as members of the Company&#8217;s Board of Directors (the &#8220;Board of Directors&#8221;), and to enable them to increase their ownership of PetMed&#8217;s Common Stock, thereby increasing their proprietary interest in PetMed and their identification with the interests of PetMed&#8217;s stockholders.&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2. STOCK SUBJECT TO THE 2015 PLAN&#59; TYPES OF AWARDS&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;The shares that may be awarded under the 2015 Plan (without payment by participants) shall be the common stock, par value $.001 per share, of the Company (&#8220;Common Stock&#8221;), and shall be authorized, but un-issued, shares.&#160;&#160;The maximum number of shares of Common Stock that may be awarded hereunder (subject to any adjustments as provided below) shall not in the aggregate exceed 400,000 shares.&#160;&#160;Shares of Common Stock forfeited as a result of a participant&#8217;s termination of service as a director or other conditions of the award not being met shall again become available for award under the 2015 Plan. The number of shares of Common Stock available for issuance under the 2015 Plan shall automatically increase on the first trading day of January each calendar year during the term of the 2015 Plan by an amount equal to ten percent (10%) of the total number of shares of Common Stock authorized under the 2015 Plan.&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following types of awards may be granted under the 2015 Plan&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Restricted Stock Award, which means a grant of shares of Common Stock that are subject to a risk of forfeiture or restrictions on transfer, or both a risk of forfeiture and restrictions on transfer, which may lapse upon the completion of a period of service or satisfaction of other conditions (which may include the achievement of performance goals established by the Committee).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Restricted Stock Units, which means the right to receive a share of Common Stock for each Restricted Stock Unit, or a cash payment the value of which is equal to the fair market value of one share of Common Stock, in each</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">case upon completion of a period of service or satisfaction of other conditions (subject to any applicable deferral</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">election that may be authorized by the Company).</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3. ADMINISTRATION&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;The 2015 Plan shall be administered by the Board of Directors (&#8220;Board&#8221;). The Board shall have the sole authority to (i) make grants of awards under the 2015 Plan&#59; (ii) interpret the Plan and the instruments evidencing awards granted under the Plan&#59; (iii) adopt, amend and rescind rules and regulations for the administration of the Plan&#59; and (iv) administer the Plan and make all determinations in connection therewith which may be necessary or advisable, and all such actions of the Board shall be binding upon all participants.&#160;  Except to the extent otherwise determined by the Board, each person who is an Outside Director immediately following an annual meeting of Stockholders each year will automatically be granted a Restricted Stock Award of 7,500 shares of Common Stock (subject to change with Board approval), and the grant date with respect to each such Restricted Stock Awards will be the date on which the annual meeting of Stockholders is held.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4. ELIGIBILITY&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Each &#8220;Outside Director&#8221; of PetMed shall be a participant in the Plan. For purposes of the Plan, an &#8220;Outside Director&#8221; is any member of PetMed&#8217;s Board of Directors who, as of the close of business on the date of the annual meeting of PetMed&#8217;s stockholders, meets the definition of &#8220;Non-Employee Director&#8221; as set forth in Rule 16b-3(b)(3)(i) adopted under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Board has the authority to determine when, and what type of, awards will be granted to Outside Directors, but unless the Board determines otherwise, annual Restricted Stock Award grants will be made to each person who is an Outside Director following each annual meeting of stockholders as set forth in Section 3 above.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a condition of the grant of an award under the 2015 Plan, each Outside Director shall execute and deliver to the Company, including through electronic medium, an agreement evidencing the award, in form and substance satisfactory to the Board, reflecting the conditions and restrictions imposed upon the award.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5. TERMS OF RESTRICTED STOCK AWARDS&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)  Rights with respect to Shares.  A participant to whom an award of Restricted Stock has been made under the 2015 Plan will have all of the rights of a stockholder with respect to the shares of Common Stock so awarded, including, but not limited to, the right to receive, subject to the following sentence, such cash dividends, if any, as may be declared on such shares from time to time and the right to vote (in person or by proxy) such shares at any meeting of the Company&#8217;s stockholders. As a condition to the grant of the award under the 2015 Plan, and without limiting the provisions of Section 5(c) hereof, dividends, if any, as may be declared on such shares of Common Stock shall be deposited into an escrow or similarly segregated account, and disbursement of such dividends to the participant will occur only upon the delivery of the shares of Common Stock to which such dividends relate, and in the event the shares of Common Stock to which such dividends relate are forfeited, the participant&#8217;s right to receive disbursement of such dividends will be forfeited and the amount of the dividends shall be returned to the Company.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Terms, Conditions and Restrictions.&#160;&#160;In addition to such other terms, conditions and&#160;&#160;restrictions (which may include performance conditions) as may be imposed by the Board and contained in the instrument under which awards of Restricted Stock are made pursuant to the 2015 Plan, (i) no Restricted&#160;Stock so awarded&#160;&#160;shall be&#160;&#160;restricted&#160;&#160;for a period&#160;&#160;(the &#8220;Restriction&#160;&#160;Period&#8221;) of less than one year or more than ten years unless otherwise specified by the Board&#59; and (ii) except as provided in paragraph (e) below, the recipient of the award shall serve as an outside director during the Restriction Period or otherwise forfeit all right, title and interest in and to the shares subject to such restrictions.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Transferability Restriction.&#160;&#160;No share awarded under the 2015 Plan shall be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of during the Restriction Period applicable thereto.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d) Certificates&#59; Stock Legend. Shares of Restricted Stock granted under the 2015 Plan shall be evidenced by certificates or book entries in the books of the Company (or, as applicable, its transfer agent). Certificates or book entries evidencing shares of Restricted Stock shall be registered in the name of the participant, shall include an appropriate legend referring to the terms, conditions, and restrictions applicable to such shares and the Company may, in its sole discretion, retain physical possession of the certificate in escrow until all restrictions have been lifted or requirements met.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e) Lapse of Restrictions.&#160;&#160;The restrictions imposed under paragraph (a) above shall terminate with respect to the shares of Common Stock to which they apply on the earliest to occur of the following, unless otherwise specified by the Board&#58;&#160;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">the expiration of the Restriction Period and, if applicable, the satisfaction of any performance goals specified in the applicable award agreement&#59;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">the participant's total and permanent disability&#59; or</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.03pt">the participant's death.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates or book entries evidencing shares of Common Stock with respect to which restrictions have lapsed as provided above shall, upon lapse thereof, be released from escrow and delivered to the participant or, in the event of participant&#8217;s death, to participant&#8217;s personal representative.&#160;&#160;Any stock legend referring to the restrictions imposed hereunder shall thereupon be removed.&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6. TERMS OF RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Terms and Conditions. Subject to the terms of this 2015 Plan, the Board will determine all terms and conditions of each award of Restricted Stock Units, including but not limited to&#58; (i) the number of Shares to which such Award relates&#59;  (ii)&#160;the length of the vesting or performance period and, if different, the date on which payment of the benefit provided under the award will be made&#59; and (iii) whether to settle such awards in cash, in shares, or in a combination of cash and shares.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) No Stockholder Rights&#59; Dividend Equivalents.  Holders of Restricted Stock Units shall not have any rights as stockholders of the Company with respect to such awards (including no voting rights or rights to receive dividends) unless and until shares of Common Stock are issued upon settlement of such awards.  However, the Board may, in its discretion, provide holders of Restricted Stock Units with the right to receive payment equal to the amount of dividends they would have received if their units had instead been outstanding shares, and such dividend equivalents will either, at the discretion of the Board, be (i) accumulated and paid, in cash or shares in the Board&#8217;s discretion, at the same time and to the same extent that the underlying Restricted Stock Unit award vests or (ii) reinvested in additional units that are subject to the same terms and conditions (including vesting and forfeiture) as the Restricted Stock Unit award to which the dividend equivalent relates.  For clarity, in no event will a director receive a dividend equivalent payment unless, until and to the same extent as the underlying Restricted Stock Unit award vests and is paid.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.1pt;padding-left:0.18pt;text-align:justify;text-indent:-0.18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;7. TERMS APPLICABLE TO ALL AWARDS</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Investment Representation.  If the shares of Common Stock that have been awarded to a participant pursuant to the terms of the 2015 Plan are not registered under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), pursuant to an exemption from registration , such participant shall be required to represent and agree in writing (i) that any shares of Common Stock acquired pursuant to the 2015 Plan will not be sold except pursuant to an effective registration statement under the Act, or pursuant to an exemption from registration under the Act, and (ii) that such participant has acquired such shares of Common Stock for the participant&#8217;s own account and not with a view to the distribution thereof.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Change of Control of the Company. Upon the occurrence of a Change of Control, unless otherwise  provided in an award agreement or specifically prohibited under applicable laws or by the rules and regulations of any governing governmental agencies or national securities exchanges, or unless the Board shall determine otherwise before the Change of Control, any Restriction Period and restrictions imposed on Restricted Stock shall terminate, and all Restricted Stock Units shall immediately vest and be settled in accordance with the terms of the award agreement, in all cases as of immediately prior to the occurrence of the Change of Control.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of the 2015 Plan, a &#8220;Change of Control&#8221; of the Company shall be deemed to have occurred if&#58;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;any person,&#160;&#160;as such term is used in Sections 13(d)(3) and 14(d)(2) of the Securities Exchange Act of 1934, as amended, becomes a beneficial owner (within the meaning of Rule 13d-3 under such Act) of 20% or more of the Company&#8217;s outstanding Common Stock&#59;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;(ii)  within any 24 month period, the persons who were directors of the Company immediately before the beginning of such period (the &#8220;Incumbent Directors&#8221;) shall cease (for any reason other than death) to constitute at least a majority of the Board or the board of directors of any successor to the Company, provided that any director who was not a director at the beginning of such period shall be deemed to be an Incumbent Director if such director (A) was elected to the Board by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually or by prior operation of this Section 7(b)(ii), and (B) was not designated by a person who has entered into an agreement with the Company to effect a transaction described in Section 7(b)(iii)&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;the Company is merged, consolidated or reorganized into or with, or sells all or substantially all of its assets to, another company or other entity, and immediately after such transaction less than 80% of the voting power of the then-outstanding securities of such company or other entity immediately after such transaction is held in the aggregate by holders of the Company&#8217;s Common Stock immediately before such transaction.&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;In addition, if the Company enters into an agreement or series of agreements or the Board adopts a resolution which results in the occurrence of any of the foregoing events, and the services of a participant is terminated after and as the sole result of the entering into of such agreement or series of agreements or the adoption of such resolution then, upon the occurrence of any of the events described&#160;&#160;above, a Change of Control shall be deemed to have retroactively occurred on the date of entering&#160;&#160;into of the earliest of such agreements or the adoption of such&#160;&#160;resolution and the participant shall be entitled to the delivery as of such date of any forfeited Restricted Stock and payment with respect to any previously forfeited Restricted Stock Units as though such participant were still in the service of the Company on the date of the Change of Control.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)  Additional Conditions. In the agreements evidencing awards or otherwise, the Board may impose such other and additional terms, conditions and restrictions upon the award as it, in its discretion, deems appropriate including, without limitation, that the Company shall have the right to deduct from payments of any kind due to the participant any federal, state or local taxes of any kind required by law to be withheld with respect to any award.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8. MISCELLANEOUS&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) No Right to Receive Award.&#160;&#160;Nothing in the 2015 Plan shall be construed to give any outside director any right to receive an award under the 2015 Plan.&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Adjustments.  If (i) the Company shall at any time be involved in a merger or other transaction in which the shares of Common Stock are changed or exchanged, (ii) the Company shall subdivide or combine the shares of Common Stock or the Company shall declare a stock dividend, (iii) the Company shall effect a cash dividend the amount of which, on a per share basis, exceeds ten percent (10%) of the fair market value of a share at the time the dividend is declared, or the Company shall effect any other dividend or other distribution in the form of cash, or a repurchase of shares, that the Board determines by resolution is special or extraordinary in nature or that is in connection with a transaction that the Company characterizes publicly as a recapitalization or reorganization involving the shares&#59; or (iv) any other event shall occur, which, in the case of this clause (iv), in the judgment of the Board necessitates an adjustment to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this 2015 Plan, then the Company shall, in such manner as it may deem equitable to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this 2015 Plan, adjust any or all of the number and type of shares subject to this 2015 Plan under Section 2, the number and type of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shares subject to outstanding awards, and the performance goals of an award. In any such case, the Board may also (or in lieu of the foregoing) make provision for a cash payment to the holder of an outstanding award in exchange for the cancellation of all or a portion of the award (without the consent of the holder of an award) in an amount determined by the Board.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any shares of Common Stock or other securities of the Company received by an outside director as a stock dividend on, or as a result of stock splits, combinations, exchanges of shares, reorganizations, mergers, consolidations or otherwise with respect to shares of Restricted Stock received pursuant to an award hereunder shall have the same status, be subject to the same restrictions and bear the same legend, if any, as the shares received pursuant to the original award.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d) Governing Law.&#160;&#160;All provisions of the 2015 Plan shall be construed in accordance with the laws of Florida except to the extent preempted by federal law.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e) No Restriction on Corporate Action.&#160;&#160;Nothing contained in the 2015 Plan shall be construed to prevent the Company or any subsidiary from taking any corporate action that is deemed by the Company or such subsidiary to be appropriate or in the best interest, whether or not such action would have an adverse effect on the 2015 Plan or any shares of Common Stock granted under the 2015 Plan.&#160;&#160;No employee, outside director, beneficiary or other person shall have any claim against the Company or any subsidiary as a result of any such action.&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9. EFFECTIVE DATE OF 2015 PLAN&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2015 Plan originally became effective on July 24, 2015, which is the date on which is was approved by the Shareholders of the Company.  This 2015 Plan is an amendment and restatement of the originally adopted plan, and such amendment and restatement was adopted and approved by the Board of Directors of the Company on June ____, 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10. AMENDMENTS&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Board may amend or terminate the 2015 Plan without shareholder approval unless shareholder approval is required by any federal or state law or regulation or the rules of The Nasdaq Stock Market. The Board shall not have the right to amend the 2015 Plan to&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;except as provided in paragraph 8(b) of the 2015 Plan, increase the maximum number of shares reserved for purposes of the 2015 Plan&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;extend the duration of the 2015 Plan&#59; or&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;materially increase the benefits&#160;accruing to participants under the 2015 Plan.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any amendment or alteration which impairs the rights of any participant with respect to an outstanding award is not effective unless written consent from the participant is obtained.</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Board may modify, amend or cancel any award granted under the 2015 Plan&#59; provided that, except as otherwise expressly provided in the 2015 Plan or the award agreement, any modification or amendment that materially diminishes the rights of a participant in the 2015 Plan or the cancellation of an award shall be effective only if agreed to by the participant, but the Board need not obtain participant consent for the modification, amendment or cancellation of an award as follows&#58; (A) to the extent the Board deems such action necessary to comply with any applicable law or the listing requirements of any principal securities exchange or market on which the Company&#8217;s shares are then traded&#59; (B) to the extent the Board deems necessary to preserve favorable accounting or tax treatment of any award for the Company&#59; or (C) to the extent the Board determines that such action does not materially and adversely affect the value of an award or that such action is in the best interest of the affected participant (or any other person(s) as may then have an interest. Notwithstanding the foregoing, unless determined otherwise by the Board, any such amendment shall be made in a manner that will enable an award intended to be exempt from Code Section 409A (as defined below) to continue to be so exempt, or to enable an award intended to comply with Code Section 409A to continue to so comply.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11. DURATION AND TERMINATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This 2015 Plan shall terminate on, and no further awards may be granted hereunder after, July 24, 2025. In addition, the Board may terminate the 2015 Plan at any time prior thereto.&#160;&#160;The termination of this 2015 Plan shall not, however, affect the validity or terms and conditions of any award properly granted hereunder before the date of termination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12. COMPLIANCE WITH SECTION 16(B)&#160;AND CODE SECTION 409A</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2015 Plan is intended to comply with all applicable conditions of Rule 16b-3 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended.&#160;&#160;All transactions involving the Company&#8217;s executive officers are subject to such conditions, regardless of whether the conditions are expressly set forth in the 2015 Plan.&#160;&#160;Any provision of the 2015 Plan that is contrary to a condition of Rule 16b-3 shall not apply to executive officers of the Company.&#160;Any award granted under the 2015 Plan shall be provided or made in such manner and at such time as to either make the award exempt from, or comply with, the provisions of Section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Code Section 409A&#8221;), to avoid a plan failure described in Code Section 409A, and the provisions of Code Section 409A are incorporated into the 2015 Plan to the extent necessary for any award that is subject to Code Section 409A to comply therewith.  For purposes of an award that is subject to Code Section 409A, if a participant&#8217;s termination of service triggers the payment of compensation under such award, then the participant will be deemed to have terminated service upon his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A. Notwithstanding any other provision in the 2015 Plan or an award to the contrary, if any participant is a &#8220;specified employee&#8221; within the meaning of Code Section 409A as of the date of his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A, then, to the extent required to avoid the imposition of additional taxes under Code Section 409A, any payment made to the participant on account of such separation from service shall not be made before a date that is six months after the date of the separation from service.  </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>a8k06152023-ex106.htm
<DESCRIPTION>EX-10.6
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="icdac4e3c63d044469dc1672586149d94_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:360pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.6</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PETMED EXPRESS, INC.<br>2015 OUTSIDE DIRECTOR EQUITY COMPENSATION</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through"><br>RESTRICTED STOCK PLAN&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">PLAN<br>(amending and restating the PetMed Express, Inc. <br>2015 Outside Director Equity Compensation Restricted Stock Plan)</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1. PURPOSE OF PLAN&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;The PetMed Express, Inc. 2015 Outside Director </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Compensation Plan, f&#47;k&#47;a the 2015 Outside Director Equity Compensation </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Award </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan (the &#8220;2015 Plan&#8221;)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> is established by PetMed Express, Inc. (&#8220;PetMed&#8221; or the &#8220;Company&#8221;) to attract, retain and compensate highly qualified individuals who are not employees or affiliates of PetMed or any of its subsidiaries, to serve as members of the Company&#8217;s Board of Directors (the &#8220;Board of Directors&#8221;), and to enable them to increase their ownership of PetMed&#8217;s Common Stock, thereby increasing their proprietary interest in PetMed and their identification with the interests of PetMed&#8217;s stockholders.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2. STOCK SUBJECT TO THE 2015 PLAN</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#59; TYPES OF AWARDS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;The shares that may be awarded under the 2015 Plan (without payment by participants) shall be the common stock, par value $.001 per share, of the Company (&#8220;Common Stock&#8221;), and shall be authorized, but un-issued, shares.&#160;&#160;The maximum number of shares of Common Stock that may be awarded hereunder (subject to any adjustments as provided below) shall not in the aggregate exceed 400,000 shares.&#160;&#160;Shares of Common Stock forfeited as a result of a participant&#8217;s termination of service as a director </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or other conditions of the award not being met </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shall again become available for award under the 2015 Plan. The number of shares of Common Stock available for issuance under the 2015 Plan shall automatically increase on the first trading day of January each calendar year during the term of the 2015 Plan by an amount equal to ten percent (10%) of the total number of shares of Common Stock authorized under the 2015 Plan.&#160;</font></div><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The following types of awards may be granted under the 2015 Plan&#58;</font></div><div><font><br></font></div><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a) Restricted Stock Award, which means a grant of shares of Common Stock that are subject to a risk of forfeiture or restrictions on transfer, or both a risk of forfeiture and restrictions on transfer, which may lapse upon the completion of a period of service or satisfaction of other conditions (which may include the achievement of performance goals established by the Committee).</font></div><div><font><br></font></div><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b) Restricted Stock Units, which means the right to receive a share of Common Stock for each Restricted Stock Unit, or a cash payment the value of which is equal to the fair market value of one share of Common Stock, in each</font></div><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">case upon completion of a period of service or satisfaction of other conditions (subject to any applicable deferral</font></div><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">election that may be authorized by the Company).</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3. ADMINISTRATION&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;The </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2015 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan shall be administered by the Board of Directors (&#8220;Board&#8221;). The Board shall have the sole authority to (i) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">award shares of Common Stock (&#8220;Restricted Stock&#8221;)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">make grants of awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> under the 2015 Plan&#59; (ii) interpret the Plan</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> the instruments evidencing </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">the restrictions imposed upon shares of Common Stock with respect to which Restricted Stock Awards are awarded</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">awards granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> under the Plan&#59; (iii) adopt, amend and rescind rules and regulations for the administration of the Plan&#59; and (iv) administer the Plan and make all determinations in connection therewith which may be necessary or advisable, and all such actions of the Board shall be binding upon all participants.&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">  Except to the extent otherwise determined by the Board, each person who is an Outside Director immediately following an annual meeting of Stockholders each year will automatically be granted a Restricted Stock Award of 7,500 shares of Common Stock (subject to change with Board approval), and the grant date with respect to each such Restricted Stock Awards will be the date on which the annual meeting of Stockholders is held.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.994%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffdead;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(a)</font></td><td colspan="3" style="background-color:#ffdead;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Initial Grants.</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;Each person who is an Outside Director as of July 24, 2015 will automatically be </font></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">granted, as of the date on which stockholder approval of the Plan is obtained, a Restricted Stock </font></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Award of 7,500 shares of Common Stock, and the Grant Date with respect to such initial Restricted</font></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Stock Awards will be the date on which stockholder approval of the Plan is obtained.</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.994%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.806%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffdead;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(b)</font></td><td colspan="3" style="background-color:#ffdead;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Annual Grants.</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;Thereafter, each person who is an Outside Director following an annual meeting of </font></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Stockholders each year will automatically be granted a Restricted Stock Award of 7,500 shares of </font></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Common Stock (subject to change with Board approval), and the Grant Date with respect to each </font></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">such Restricted Stock Awards will be the date on which the award is granted.</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4. ELIGIBILITY&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Each &#8220;Outside Director&#8221; of PetMed shall be a participant in the Plan. For purposes of the Plan, an &#8220;Outside Director&#8221; is any member of PetMed&#8217;s Board of Directors who, as of the close of business on the date of the annual meeting of PetMed&#8217;s stockholders, meets the definition of &#8220;Non-Employee Director&#8221; as set forth in Rule 16b-3(b)(3)(i) adopted under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Board has the authority to determine when, and what type of, awards will be granted to Outside Directors, but unless the Board determines otherwise, annual Restricted Stock Award grants will be made to each person who is an Outside Director following each annual meeting of stockholders as set forth in Section 3 above.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">As a condition of </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the grant of an award </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">under the 2015 Plan, each Outside Director </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">shall execute and deliver to the Company</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, including through electronic medium, an agreement evidencing the award, </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">in form and substance satisfactory to the Board</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">reflecting the conditions and restrictions imposed upon the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">award.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5. </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">RIGHTS WITH RESPECT TO SHARES</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">TERMS OF RESTRICTED STOCK AWARDS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a)  Rights with respect to Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A participant to whom an award of Restricted Stock has been made under the 2015 Plan will have all of the rights of a stockholder with respect to the shares of Common Stock so awarded, including, but not limited to, the right to receive, subject to the following sentence, such cash dividends, if any, as may be declared on such shares from time to time and the right to vote (in person or by proxy) such shares at any meeting of the Company&#8217;s stockholders. As a condition to the grant of the award under the 2015 Plan, and without limiting the provisions of Section </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">7</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">b</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) hereof, dividends, if any, as may be declared on such shares of Common Stock shall be deposited into an escrow or similarly segregated account, and disbursement of such dividends to the participant will occur only upon the delivery of the shares of Common Stock to which such dividends relate, and in the event the shares of Common Stock to which such dividends relate are forfeited, the participant&#8217;s right to receive disbursement of such dividends will be forfeited and the amount of the dividends shall be returned to the Company.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;6. INVESTMENT REPRESENTATION&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">If the shares of Common Stock </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">underlying the Restricted Stock Award granted </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">to a participant pursuant to the terms of the Plan are not registered under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), pursuant to an exemption from registration , such participant shall be required to represent and agree in writing (i) that any shares of Common Stock acquired pursuant to the Plan will not be sold except pursuant to an effective registration statement under the Act, or pursuant to an exemption from registration under the Act, and (ii) that such participant has acquired such shares of Common Stock for the participant&#8217;s own account and not with a view to the distribution thereof.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">7. RESTRICTIONS&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) Terms, Conditions and Restrictions.&#160;&#160;In addition to such other terms, conditions and&#160;&#160;restrictions </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(which may include performance conditions) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">as may be imposed by the Board and contained in the instrument under which awards of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Common</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Stock are made pursuant to the 2015 Plan, (i) no </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Common&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Stock so awarded&#160;&#160;shall be&#160;&#160;restricted&#160;&#160;for a period&#160;&#160;(the &#8220;Restriction&#160;&#160;Period&#8221;) of less than one year or more than ten years unless otherwise specified by the Board&#59; and (ii) except as provided in paragraph (e) below, the recipient of the award shall serve as an outside director during the Restriction Period or otherwise forfeit all right, title and interest in and to the shares subject to such restrictions.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">b</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) Transferability Restriction.&#160;&#160;No share awarded under the 2015 Plan shall be sold, assigned, transferred, pledged, hypothecated or otherwise disposed of during the Restriction Period applicable thereto.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">c</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Agreements</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#59; Stock Legend. </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">As a condition to </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">the grant of an award</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Shares of Restricted Stock granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> under the 2015 Plan</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">, all outside directors </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">shall execute and deliver to the Company </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">an agreement </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">in form and substance satisfactory to the Board reflecting the conditions and restrictions imposed upon the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Common Stock awarded.&#160;&#160;Certificates for shares of Common Stock delivered pursuant to such awards may, if the Board so determines, bear a </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> shall be evidenced by certificates </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or book entries in the books of the Company (or, as applicable, its transfer agent). Certificates or book entries evidencing shares of </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock shall be registered in the name of the participant, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">shall include an appropriate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">legend referring to the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">terms, conditions, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">restrictions </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">and the instruments to which such awards are subject.&#160;</font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">applicable to such shares and the Company </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">may, in its sole discretion, </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">retain physical possession of the certificate in escrow until all restrictions have been lifted or requirements met.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(d</font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">) Additional Conditions. In the agreements evidencing awards or otherwise, the Board may impose such other and additional terms, conditions and restrictions upon the award as it, in its discretion, deems appropriate including, without limitation, that the Company shall have the right to deduct from payments of any kind due to the participant any federal, state or local taxes of any kind required by law to be withheld with respect to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">the shares awarded.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e) Lapse of Restrictions.&#160;&#160;The restrictions imposed under paragraph (a) above shall terminate with respect to the shares of Common Stock to which they apply on the earliest to occur of the following, unless otherwise specified by the Board&#58;&#160;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">the expiration of the Restriction Period</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> and, if applicable, the satisfaction of any performance goals specified in the applicable award agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#59;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.8pt">the participant's total and permanent disability&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.03pt">the participant's death.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">for</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">or book entries evidencing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> shares of Common Stock with respect to which restrictions have lapsed as provided above shall, upon lapse thereof, be released from escrow and delivered to the participant or, in the event of participant&#8217;s death, to participant&#8217;s personal representative.&#160;&#160;Any stock legend referring to the restrictions imposed hereunder shall thereupon be removed.&#160;</font></div><div style="margin-bottom:10pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">6. TERMS OF RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a) Terms and Conditions. Subject to the terms of this 2015 Plan, the Board will determine all terms and conditions of each award of Restricted Stock Units, including but not limited to&#58; (i) the number of Shares to which such Award relates&#59;  (ii)&#160;the length of the vesting or performance period and, if different, the date on which payment of the benefit provided under the award will be made&#59; and (iii) whether to settle such awards in cash, in shares, or in a combination of cash and shares.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b) No Stockholder Rights&#59; Dividend Equivalents.  Holders of Restricted Stock Units shall not have any rights as stockholders of the Company with respect to such awards (including no voting rights or rights to receive dividends) unless and until shares of Common Stock are issued upon settlement of such awards.  However, the Board may, in its discretion, provide holders of Restricted Stock Units with the right to receive payment equal to the amount of dividends they would have received if their units had instead been outstanding shares, and such dividend equivalents will either, at the discretion of the Board, be (i) accumulated and paid, in cash or shares in the Board&#8217;s discretion, at the same time and to the same extent that the underlying Restricted Stock Unit award vests or (ii) reinvested in additional units that are subject to the same terms and conditions (including vesting and forfeiture) as the Restricted Stock Unit award to which the dividend equivalent relates.  For clarity, in no event will a director receive a dividend equivalent payment unless, until and to the same extent as the underlying Restricted Stock Unit award vests and is paid.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;7. TERMS APPLICABLE TO ALL AWARDS</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(a) Investment Representation.  </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">If the shares of Common Stock </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">that have been awarded </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">to a participant pursuant to the terms of the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2015 </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan are not registered under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), pursuant to an exemption from registration , such participant shall be required to represent and agree in writing (i) that any shares of Common Stock acquired pursuant to the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2015 </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Plan will not be sold except pursuant to an effective registration statement under the Act, or pursuant to an exemption from registration under the Act, and (ii) that such participant has acquired such shares of Common Stock for the participant&#8217;s own account and not with a view to the distribution thereof.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">f</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">) Change of Control of the Company. Upon the occurrence of a Change of Control, unless otherwise </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> provided in an award agreement or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">specifically prohibited under applicable laws or by the rules and regulations of any governing governmental agencies or national securities exchanges, or unless the Board shall determine otherwise</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> before the Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, any Restriction Period and restrictions imposed on Restricted Stock shall terminate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">, and all Restricted Stock Units shall immediately vest and be settled in accordance with the terms of the award agreement, in all cases as of immediately prior to the occurrence of the Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of the 2015 Plan, a &#8220;Change </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Control&#8221; of the Company shall be deemed to have occurred if&#58;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">i</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)&#160;&#160;any person,&#160;&#160;as such term is used in Sections 13(d)(3) and 14(d)(2) of the Securities Exchange Act of 1934, as amended, becomes a beneficial owner (within the meaning of Rule 13d-3 under such Act) of 20% or more of the Company&#8217;s outstanding Common Stock&#59;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;&#160;&#160;&#160;&#160;(b) there occurs within any period of two consecutive years any change in&#160;&#160;the directors of the Company&#160;&#160;such that the members of the Company&#8217;s Board of Directors prior to such change do not constitute a majority of the&#160;&#160;directors after giving effect to all changes during such two-year period unless the election, or the nomination for election by the Company&#8217;s stockholders, of each new director was approved by a vote of at least&#160;&#160;two-thirds of the directors then still in office who were directors at the beginning of the period&#59; or&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;(ii)  within any 24 month period, the persons who were directors of the Company immediately before the beginning of such period (the &#8220;Incumbent Directors&#8221;) shall cease (for any reason other than death) to constitute at least a majority of the Board or the board of directors of any successor to the Company, provided that any director who was not a director at the beginning of such period shall be deemed to be an Incumbent Director if such director (A) was elected to the Board by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually or by prior operation of this Section 7(b)(ii), and (B) was not designated by a person who has entered into an agreement with the Company to effect a transaction described in Section 7(b)(iii)&#59;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">c</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">iii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)&#160;&#160;the Company is merged, consolidated or reorganized into or with, or sells all or substantially all of its assets to, another company or other entity, and immediately after such transaction less than 80% of the voting power of the then-outstanding securities of such company or other entity immediately after such transaction is held in the aggregate by holders of the Company&#8217;s Common Stock immediately before such transaction.&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;In addition, if the Company enters into an agreement or series of agreements or the Board </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">of Directors of the Company </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">adopts a resolution which results in the occurrence of any of the foregoing events, and the services of a participant is terminated after and as the sole result of the entering into of such agreement or series of agreements or the adoption of such resolution then, upon the occurrence of any of the events described&#160;&#160;above, a Change </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Control shall be deemed to have retroactively occurred on the date of entering&#160;&#160;into of the earliest of such agreements or the adoption of such&#160;&#160;resolution and the participant shall be entitled to the delivery as of such date of any forfeited Restricted Stock</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> and payment with respect to any previously forfeited Restricted Stock Units as though such participant were still in the service of the Company on the date of the Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(c</font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">)  Additional Conditions. In the agreements evidencing awards or otherwise, the Board may impose such other and additional terms, conditions and restrictions upon the award as it, in its discretion, deems appropriate including, without limitation, that the Company shall have the right to deduct from payments of any kind due to the participant any federal, state or local taxes of any kind required by law to be withheld with respect to </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">any award.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8. MISCELLANEOUS&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) No Right to Receive Award.&#160;&#160;Nothing in the 2015 Plan shall be construed to give any outside director any right to receive an award under the 2015 Plan.&#160;</font></div><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(b) Adjustments.  If (i) the Company shall at any time be involved in a merger or other transaction in which the shares of Common Stock are changed or exchanged, (ii) the Company shall subdivide or combine the shares of Common Stock or the Company shall declare a stock dividend, (iii) the Company shall effect a cash dividend the amount of which, on a per share basis, exceeds ten percent (10%) of the fair market value of a share at the time the dividend is declared, or the Company shall effect any other dividend or other distribution in the form of cash, or a repurchase of shares, that the Board determines by resolution is special or extraordinary in nature or that is in connection with a transaction that the Company characterizes publicly as a recapitalization or reorganization involving the shares&#59; or (iv) any other event shall occur, which, in the case of this clause (iv), in the judgment of the Board necessitates an adjustment to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this 2015 Plan, then the Company shall, in such manner as it may deem equitable to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this 2015 Plan, adjust any or all of the number and type of shares subject to this 2015 Plan under Section 2, the number and type of shares subject to outstanding awards, and the performance goals of an award. In any such case, the Board may also (or in lieu of the foregoing) make provision for a cash payment to the holder of an outstanding award in exchange for the cancellation of all or a portion of the award (without the consent of the holder of an award) in an amount determined by the Board.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(b) Additional Shares Received With Respect to Restricted Stock. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any shares of Common Stock or other securities of the Company received by an outside director as a stock dividend on, or as a result of stock splits, combinations, exchanges of shares, reorganizations, mergers, consolidations or otherwise with respect to shares of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Common</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Stock received pursuant to an award hereunder shall have the same status, be subject to the same restrictions and bear the same legend, if any, as the shares received pursuant to the original award.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">(c) Certificates for Shares</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:line-through">.</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">&#160;&#160;Shares of Restricted Stock granted under the 2015 Plan </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">shall be evidenced by certificates</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">. Certificates representing the </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">Restricted Stock shall be registered in the name of the participant, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">such certificates shall bear an appropriate legend referring to the terms, conditions, and restrictions </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">applicable to such shares and the Company </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">shall </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">retain physical possession of the certificate in escrow until all restrictions have been lifted or requirements met.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d) Governing Law.&#160;&#160;All provisions of the 2015 Plan shall be construed in accordance with the laws of Florida except to the extent preempted by federal law.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e) No Restriction on Corporate Action.&#160;&#160;Nothing contained in the 2015 Plan shall be construed to prevent the Company or any subsidiary from taking any corporate action that is deemed by the Company or such subsidiary to be appropriate or in the best interest, whether or not such action would have an adverse effect on the 2015 Plan or any shares of Common Stock granted under the 2015 Plan.&#160;&#160;No employee, outside director, beneficiary or other person shall have any claim against the Company or any subsidiary as a result of any such action.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9. EFFECTIVE DATE OF 2015 PLAN&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2015 Plan </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">shall become</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">originally became</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> effective </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">when</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">on July 24, 2015, which is the date on which is was</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> approved by the Shareholders of the Company. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> This 2015 Plan is an amendment and restatement of the originally adopted plan, and such amendment and restatement was adopted and approved by the Board </font><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">of Directors of the Company </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">on June ____, 2023.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10. AMENDMENTS&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Board may amend or terminate the 2015 Plan without shareholder approval unless shareholder approval is required by any federal or state law or regulation or the rules of The Nasdaq Stock Market. The Board shall not have the right to amend the 2015 Plan to&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">i</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)&#160;&#160;&#160;&#160;except as provided in paragraph 8(b) of the 2015 Plan, increase the maximum number of shares reserved for purposes of the 2015 Plan&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">ii</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)&#160;&#160;&#160;extend the duration of the 2015 Plan&#59; or&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">iii</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)&#160;&#160;&#160;materially increase the benefits&#160;accruing to participants under the 2015 Plan.&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any amendment or alteration which impairs the rights of any participant </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">during the Restriction Period</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">with respect to an outstanding award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> is not effective unless written consent from the participant is obtained.</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The Board may modify, amend or cancel any award granted under the 2015 Plan&#59; provided that, except as otherwise expressly provided in the 2015 Plan or the award agreement, any modification or amendment that materially diminishes the rights of a participant in the 2015 Plan or the cancellation of an award shall be effective only if agreed to by the participant, but the Board need not obtain participant consent for the modification, amendment or cancellation of an award as follows&#58; (A) to the extent the Board deems such action necessary to comply with any applicable law or the listing requirements of any principal securities exchange or market on which the Company&#8217;s shares are then traded&#59; (B) to the extent the Board deems necessary to preserve favorable accounting or tax treatment of any award for the Company&#59; or (C) to the extent the Board determines that such action does not materially and adversely affect the value of an award or that such action is in the best interest of the affected participant (or any other person(s) as may then have an interest. Notwithstanding the foregoing, unless determined otherwise by the Board, any such amendment shall be made in a manner that will enable an award intended to be exempt from Code Section 409A (as defined below) to continue to be so exempt, or to enable an award intended to comply with Code Section 409A to continue to so comply.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11. DURATION AND TERMINATION&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This 2015 Plan shall terminate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> on</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, and no further </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">stock shall be awarded</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">awards may be granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> hereunder</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> after</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> July 24, 2025. In addition, the Board may terminate the 2015 Plan at any time prior thereto.&#160;&#160;The termination of this 2015 Plan shall not, however, affect </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:line-through">any restriction previously imposed or restricted stock awarded pursuant to this 2015 Plan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">the validity or terms and conditions of any award properly granted hereunder before the date of termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12. COMPLIANCE WITH SECTION 16(B)&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">AND CODE SECTION 409A</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The 2015 Plan is intended to comply with all applicable conditions of Rule 16b-3 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended.&#160;&#160;All transactions involving the Company&#8217;s executive officers are subject to such conditions, regardless of whether the conditions are expressly set forth in the 2015 Plan.&#160;&#160;Any provision of the 2015 Plan that is contrary to a condition of Rule 16b-3 shall not apply to executive officers of the Company.&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Any award granted under the 2015 Plan shall be provided or made in such manner and at such time as to either make the award exempt from, or comply with, the provisions of Section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Code Section 409A&#8221;), to avoid a plan failure described in Code Section 409A, and the provisions of Code Section 409A are incorporated into the 2015 Plan to the extent necessary for any award that is subject to Code Section 409A to comply therewith.  For purposes of an award that is subject to Code Section 409A, if a participant&#8217;s termination of service triggers the payment of compensation under such award, then the participant will be deemed to have terminated service upon his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A. Notwithstanding any other provision in the 2015 Plan or an award to the contrary, if any participant is a &#8220;specified employee&#8221; within the meaning of Code Section 409A as of the date of his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A, then, to the extent required to avoid the imposition of additional taxes under Code Section 409A, any payment made to the participant on account of such separation from service shall not be made before a date that is six months after the date of the separation from service.  </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="icdac4e3c63d044469dc1672586149d94_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:34pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.576%"><tr><td style="width:1.0%"></td><td style="width:76.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Summary report&#58; </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Litera&#174; Change-Pro for Word 10.14.0.46 Document comparison done on 6&#47;16&#47;2023 1&#58;11&#58;39 PM</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Style name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Default Style</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Intelligent Table Comparison&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Active</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Original filename&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PetMed -2015 Outside Director Equity Compensation Plan (as amended and restated) 4854-8839-6905 v.1.docx</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Modified filename&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PetMed -2015 Outside Director Equity Compensation Plan (as amended and restated) 4854-8839-6905 v.6.docx</font></div></td></tr><tr><td colspan="6" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Changes&#58;</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Add</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">81</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Delete</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">48</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Move From</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Move To</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Table Insert</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Table Delete</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Table moves to</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#008000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">Table moves from</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Embedded Graphics (Visio, ChemDraw, Images etc.)</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Embedded Excel</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Format changes</font></td><td colspan="3" style="border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">0</font></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Total Changes&#58;</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:0.75pt solid #000000;border-right:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">161</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>8
<FILENAME>a8k06152023-ex107.htm
<DESCRIPTION>EX-10.7
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5845c8016b6b4c84ac08dc7e4291ee60_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:360pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.7</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AGREEMENT PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC. 2015 DIRECTOR EQUITY COMPENSATION PLAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">      THIS RESTRICTED STOCK UNIT AGREEMENT (&#8220;Agreement&#8221;) is made this ___ day of ____, 202_ by and between _______________ (the &#34;Director&#34;) and PetMed Express, Inc., a Florida corporation, on behalf of itself, its subsidiaries and affiliates (collectively, the &#34;Company&#34;) pursuant to the Company's 2015 Director Equity Compensation Plan (the &#34;2015 Plan&#34;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     WHEREAS, the Company desires to award the Director restricted stock units representing the right to receive shares of the Company&#8217;s common stock, subject to the terms and conditions as hereinafter provided, in accordance with the provisions of the 2015 Plan, the terms of which are incorporated by reference herein, and a copy of the 2015 Plan is being provided to the Director herewith.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     NOW THEREFORE, in consideration of the foregoing and the mutual undertakings herein contained, the parties hereto agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1. Grant of Restricted Stock Units.  In accordance with the terms of the 2015 Plan and subject to the further terms, conditions and restrictions contained in this Agreement, the Company hereby grants to the Director _______ restricted stock units (the &#34;Restricted Stock Units&#34;), each of which represents the right to receive one share of the Company's common stock, par value $.001 per share (the &#34;Common Stock&#34;) upon vesting as described herein.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.  Adjustments.  In the event of any change in the outstanding Common Stock by reason of a stock dividend or distribution, recapitalization, merger, consolidation, split-up, combination, exchange of shares or the like, the Committee shall make equitable adjustments in the Restricted Stock Units corresponding to adjustments made by the Committee in the number and class of shares of Common Stock which may be issued under the 2015 Plan. The adjusted award shall be subject to the same terms, conditions, and restrictions as described herein. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.  No Transfer.  The Restricted Stock Units may not be sold, assigned, transferred, exchanged, pledged, hypothecated or otherwise encumbered or disposed of.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4. Vesting and Forfeiture.  (a) Except as provided in subsection (b) below or in the Plan, the Restricted Stock Units granted under this Agreement shall vest ratably on each of the below indicated dates in accordance with the schedule below, provided that the Director is continuously employed by, or in the service of, the Company through the applicable vesting date&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:50.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.923%"><tr><td style="width:1.0%"></td><td style="width:53.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.750%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting Date(s)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) In the event that a Director's service as an outside director terminates as a result of his or her death or total and permanent disability, then the Restricted Stock Units shall become fully vested as of the date of the Director&#8217;s termination of service.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (c)  For clarity, if the Director&#8217;s service terminates for any reason other than his or her death or disability, then (except as otherwise provided in the 2015 Plan), any Restricted Stock Units that are unvested as of the date of the Director&#8217;s termination shall be forfeited and no payment will be due thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)  Upon a Change of Control, the Restricted Stock Units granted under this Agreement will vest  in accordance with Section 7(b) of the 2015 Plan.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.  Settlement.  Upon vesting, the Company shall, as soon as practicable thereafter (but in no event later than the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> day of the third month following the end of the fiscal year in which vesting occurs), deliver to the Director, or to the Director's personal representative, a number of shares of Common Stock equal to the number of Restricted Stock Units that vested in either certificate or electronic form. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6. Shareholder Rights.  The Director will not be deemed for any purposes to be a stockholder of the Company with respect to any of the Restricted Stock Units (including with respect to voting or dividends) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">unless and until a certificate for shares of Common Stock is issued upon vesting of the Restricted Stock Units. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.  Tax Matters.  Director shall be responsible for satisfying any Federal, state or local withholding tax requirements associated with the grant, vesting or settlement of the Restricted Stock Units.</font><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8. Effect of Employment.  Nothing contained in this Agreement shall confer upon the Director the right to continue as an Outside Director.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9. Amendment.  This Agreement may not be amended or modified except with the consent of the Committee and by a written instrument duly executed by the Director and the Company, except as may be permitted by the 2015 Plan.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10. Binding Effect.  This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their heirs, personal representatives, successors and assigns.  Director acknowledges receipt of a copy of the 2015 Plan, which is annexed hereto, represents that he or she is familiar with the terms and provisions thereof and accepts the award of Restricted Stock Units hereunder subject to all of the terms and conditions thereof and of this Agreement.  Director hereby agrees to accept as binding, conclusive and final all decisions and interpretations of the Committee upon any questions arising under the 2015 Plan or this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company and the Director have each executed and delivered this Agreement as of the date first above written.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPANY&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__________________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________&#91;name and title&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIRECTOR&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">___________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________&#91;name&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>pets-20230615.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:0995af87-8441-4a17-9983-cd5ba40a2d1c,g:3ff95010-c02b-4337-b1d5-48a25c9c26fe-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pets="http://www.1800petmeds.com/20230615" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.1800petmeds.com/20230615">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20230615_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20230615_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.1800petmeds.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>pets-20230615_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:0995af87-8441-4a17-9983-cd5ba40a2d1c,g:3ff95010-c02b-4337-b1d5-48a25c9c26fe-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_638303b1-5607-4c3d-b652-e86234338064_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_82218cd3-00c2-45ef-81eb-043052151aed_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b9ab56a2-978c-4809-9142-da876c3efa60_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cafc2392-6f61-43d7-ba80-ab62b8ccfbb0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a87d9f06-c85a-4b7d-89dd-d0cf92463e99_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_95c4d23a-5abc-461e-91a8-d92d75898786_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_40118e19-c5eb-4144-a5ec-4459004da223_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_e500da48-0472-4cab-88ba-60bf4132a421_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_bb270bf0-e55a-4728-9757-c4a1884a6180_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7baf6ae0-6dc7-43b2-8381-32c47c836758_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_626bfa01-ada6-4d7e-9301-c6c2c298a9a7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_5a062d8d-2fc9-493a-8fbf-8f5ce1a0a51b_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_10e77847-c1fe-4f68-bad4-764d2377bcc2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b8c8bc8d-5c48-48de-9d48-a0931b334c49_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3d4165c6-cc12-4112-bf59-e9e1aee58073_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_75fe4c12-afc2-475f-8a00-1ec810c20811_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2048f9e6-1f3b-4e89-8b6d-c83bb9fafba6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_978f7e58-e294-493a-8631-e0e1de9c1388_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6bdb8ca4-d527-478a-b23b-d42fc24aef6e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a9ef3cce-b160-4cd9-bef4-3e86e26e165a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_83348f75-dff9-45f0-b543-f84d378e0c07_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_5f9c0566-e315-4e96-9abe-e11498b64a70_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>pets-20230615_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:0995af87-8441-4a17-9983-cd5ba40a2d1c,g:3ff95010-c02b-4337-b1d5-48a25c9c26fe-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.1800petmeds.com/role/Cover" xlink:type="simple" xlink:href="pets-20230615.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d7ba590d-501d-4151-9042-2f574b65ba9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_DocumentType_d7ba590d-501d-4151-9042-2f574b65ba9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_fa4f7509-a051-47e2-baf1-70d4e68f9a13" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_DocumentPeriodEndDate_fa4f7509-a051-47e2-baf1-70d4e68f9a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_44c17210-3720-4c35-af35-7bf0a47b464b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_EntityRegistrantName_44c17210-3720-4c35-af35-7bf0a47b464b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b642587b-54bd-408e-abfa-5786d377541b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b642587b-54bd-408e-abfa-5786d377541b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0682cc36-7f8f-4224-aa34-9a295621a022" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_EntityFileNumber_0682cc36-7f8f-4224-aa34-9a295621a022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_358107fe-5f13-4fe4-89ac-f85cc903684e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_EntityTaxIdentificationNumber_358107fe-5f13-4fe4-89ac-f85cc903684e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e073e995-5b7d-48ea-9d90-f373ed8acae2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_EntityAddressAddressLine1_e073e995-5b7d-48ea-9d90-f373ed8acae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e3e00263-7a5c-407d-86a3-c3661e58b2ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_EntityAddressCityOrTown_e3e00263-7a5c-407d-86a3-c3661e58b2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_bb134142-799e-4db0-a2b3-6e2a57dcb537" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_EntityAddressStateOrProvince_bb134142-799e-4db0-a2b3-6e2a57dcb537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_704e680b-dfe8-45de-9e18-db4d83fab818" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_EntityAddressPostalZipCode_704e680b-dfe8-45de-9e18-db4d83fab818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a1494e8f-255e-4a9a-8f15-5df4a2447894" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_CityAreaCode_a1494e8f-255e-4a9a-8f15-5df4a2447894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3fed97e5-ac93-4c0d-bc9f-139ac4827a2e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_LocalPhoneNumber_3fed97e5-ac93-4c0d-bc9f-139ac4827a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_fd2d0cc3-452f-45b3-8873-9c6b47b68e1e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_WrittenCommunications_fd2d0cc3-452f-45b3-8873-9c6b47b68e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_fe2c89e5-d8a0-4067-a802-9d4daf4233d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_SolicitingMaterial_fe2c89e5-d8a0-4067-a802-9d4daf4233d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_3abca75d-3a73-4650-a90b-9214c434444e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_PreCommencementTenderOffer_3abca75d-3a73-4650-a90b-9214c434444e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_96b26d5d-59a4-43ab-8a5a-c2409797a442" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_96b26d5d-59a4-43ab-8a5a-c2409797a442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_aad50237-ead2-49f9-9945-9df9ddedf0ed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_Security12bTitle_aad50237-ead2-49f9-9945-9df9ddedf0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8cb8bb08-595a-43d0-a5b9-1d49ef013e5d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_TradingSymbol_8cb8bb08-595a-43d0-a5b9-1d49ef013e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ff3e13e9-7d13-4da9-8407-da94c66ca3d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_EntityEmergingGrowthCompany_ff3e13e9-7d13-4da9-8407-da94c66ca3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0c4b85fd-c40a-4cd4-9121-824322d4e3d8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_EntityCentralIndexKey_0c4b85fd-c40a-4cd4-9121-824322d4e3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6879b34a-338d-4790-9c95-f9e10d41cbe4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_AmendmentFlag_6879b34a-338d-4790-9c95-f9e10d41cbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d65d4faf-8ad0-417d-ad29-60326a96efcb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f97dc749-631d-4ebb-8202-ea0d543f2dc2" xlink:to="loc_dei_SecurityExchangeName_d65d4faf-8ad0-417d-ad29-60326a96efcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140530812604672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 16, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 15,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PetMed Express, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-28827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0680967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">420 South Congress Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Delray Beach<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">526-4444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PETS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001040130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>pets-20230615_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pets-20230615.xsd" xlink:type="simple"/>
    <context id="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2023-05-16</startDate>
            <endDate>2023-05-16</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF80L2ZyYWc6OGZkNmY1M2Q0MTU4NGJlZjk5NGUzOTQ4ZTFmM2RhZTQvdGFibGU6MDlmYjkyNmJlZDYwNDMwMDk3MTU1Y2JkMTFlNGQ0YjUvdGFibGVyYW5nZTowOWZiOTI2YmVkNjA0MzAwOTcxNTVjYmQxMWU0ZDRiNV8xLTEtMS0xLTYwNTI2_7196e62e-0a78-4eb6-8882-31a94b2970a2">0001040130</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF80L2ZyYWc6OGZkNmY1M2Q0MTU4NGJlZjk5NGUzOTQ4ZTFmM2RhZTQvdGFibGU6MDlmYjkyNmJlZDYwNDMwMDk3MTU1Y2JkMTFlNGQ0YjUvdGFibGVyYW5nZTowOWZiOTI2YmVkNjA0MzAwOTcxNTVjYmQxMWU0ZDRiNV8yLTEtMS0xLTYwNTI2_61ba15f3-7736-4a1d-a8dc-107bda1892c4">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzU5_16c580aa-843c-4e48-910d-6f89fc570697">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzYw_ef3f44dd-74b9-4fdc-868e-bf82c134e156">2023-06-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzYy_3c774c2c-cfb7-4f78-bceb-0c85dfb1cdc3">PetMed Express, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6MTI1NzMzYzU5OWE0NDNkNThiOWFhZmRhNmIzMjA3YjEvdGFibGVyYW5nZToxMjU3MzNjNTk5YTQ0M2Q1OGI5YWFmZGE2YjMyMDdiMV8wLTAtMS0xLTYwNTI2_5f12460f-5513-4d45-85af-2258d956b4da">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6MTI1NzMzYzU5OWE0NDNkNThiOWFhZmRhNmIzMjA3YjEvdGFibGVyYW5nZToxMjU3MzNjNTk5YTQ0M2Q1OGI5YWFmZGE2YjMyMDdiMV8wLTItMS0xLTYwNTI2_0f6c9a57-e958-4c33-b1aa-f9336912c0ce">000-28827</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6MTI1NzMzYzU5OWE0NDNkNThiOWFhZmRhNmIzMjA3YjEvdGFibGVyYW5nZToxMjU3MzNjNTk5YTQ0M2Q1OGI5YWFmZGE2YjMyMDdiMV8wLTQtMS0xLTYwNTI2_0d3bc073-2532-4662-b71c-f983d8bfbb68">65-0680967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzY1_28a942d0-d621-41c0-87aa-f5bf26c3d510">420 South Congress Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzY2_f1f3477b-6579-42b8-a647-e71addc3bb9d">Delray Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzYz_687b9918-bccb-418a-a020-67f06f37fe91">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzY3_357837cd-ae6d-44e2-a91b-f8fa98143f04">33445</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF80MjM_56fafcfa-fd4d-49db-88a3-c8264a33aae3">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzU3_14123da4-cc26-46f8-b475-399ea40f61ee">526-4444</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NDc2YTRhODZkMmRiNDZjZmIzOWNjZjg2YTRiODEyMjAvdGFibGVyYW5nZTo0NzZhNGE4NmQyZGI0NmNmYjM5Y2NmODZhNGI4MTIyMF8wLTAtMS0xLTYwNTI2_9d6e331a-dba5-49ad-9323-128d44ca5e40">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NDc2YTRhODZkMmRiNDZjZmIzOWNjZjg2YTRiODEyMjAvdGFibGVyYW5nZTo0NzZhNGE4NmQyZGI0NmNmYjM5Y2NmODZhNGI4MTIyMF8yLTAtMS0xLTYwNTI2_371715d8-822e-4c37-ab7c-e6feace8380b">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NDc2YTRhODZkMmRiNDZjZmIzOWNjZjg2YTRiODEyMjAvdGFibGVyYW5nZTo0NzZhNGE4NmQyZGI0NmNmYjM5Y2NmODZhNGI4MTIyMF80LTAtMS0xLTYwNTI2_186f5b24-d48e-4212-9526-b5272885f758">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NDc2YTRhODZkMmRiNDZjZmIzOWNjZjg2YTRiODEyMjAvdGFibGVyYW5nZTo0NzZhNGE4NmQyZGI0NmNmYjM5Y2NmODZhNGI4MTIyMF82LTAtMS0xLTYwNTI2_d67178c2-b702-40d2-998d-a7215cd2e351">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NGRiN2U5ZWM2YTJkNDIyOWFhYmI0YmQ5NGY3YzVkZDUvdGFibGVyYW5nZTo0ZGI3ZTllYzZhMmQ0MjI5YWFiYjRiZDk0ZjdjNWRkNV8xLTAtMS0xLTYwNTI2_56d58696-aab8-4f40-a115-4838f0ab400a">Common Stock, par value $.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NGRiN2U5ZWM2YTJkNDIyOWFhYmI0YmQ5NGY3YzVkZDUvdGFibGVyYW5nZTo0ZGI3ZTllYzZhMmQ0MjI5YWFiYjRiZDk0ZjdjNWRkNV8xLTEtMS0xLTYwNTI2_629e7028-c523-4aac-bd95-6b48f168620a">PETS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGFibGU6NGRiN2U5ZWM2YTJkNDIyOWFhYmI0YmQ5NGY3YzVkZDUvdGFibGVyYW5nZTo0ZGI3ZTllYzZhMmQ0MjI5YWFiYjRiZDk0ZjdjNWRkNV8xLTItMS0xLTYwNTI2_4cdb63f0-80fa-4eaa-81b4-cfcc9525dec8">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9365390939e54ea8b43dd533fbda674c_D20230516-20230516"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhMmJkNWFhZjM3YTRlN2U5NGNkYzY2ZGRlZGU4OTU0L3NlYzpiYTJiZDVhYWYzN2E0ZTdlOTRjZGM2NmRkZWRlODk1NF8xL2ZyYWc6OGViODNiYzJjNmRhNGZhNDk0OTkyOGQ2M2FjZTVlNDAvdGV4dHJlZ2lvbjo4ZWI4M2JjMmM2ZGE0ZmE0OTQ5OTI4ZDYzYWNlNWU0MF8xMzU4_0315b95d-8d62-4219-8206-a3f5f0c4c5b0">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !=5-161JGF%T8$  "$$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)68;V_J-A3&OXJ53=,FM>0/@=(.D"AMM^ZVO:RP76G37IC$$*N)G=D.E&^_
MXT 3IAM.N'U1XB3GX6?[^#DVPZU4;SIAS)#W+!5ZY"3&Y#>NJZ.$951W9,X$
M/%E)E5$#3;5V=:X8C<N@+'4#S^N[&>7"&0_+>S,U'LK"I%RPF2*ZR#*J=K<L
ME=N1XSL?-U[Y.C'VACL>YG3-YLS\D<\4M-Q*)>89$YI+011;C9R)?W,;A#:@
M?.-/SK;ZZ)K8KBRE?+.-QWCD>):(I2PR5H+"QX9-69I:)>#X]R#J5-]I X^O
M/]0?RLY#9Y94LZE,O_#8)"-GX)"8K6B1FE>Y_94=.M2S>I%,=?F?;/?OAJ%#
MHD(;F1V"@2#C8O])WP\#<1S@G0@(#@%!R;W_HI+RCAHZ'BJY)<J^#6KVHNQJ
M&0UP7-A9F1L%3SG$F?%4;I@:N@:D[ TW.H3=[L."$V'/=$?\_@4)O*#[_V@7
M "J*H*((2KDN1D'^GBRU43!/_S0![17"9@6;O#<ZIQ$;.9"=FJD-<\8_?.?W
MO9\1OF[%U\74QW<R*B 5#5GL<M8$AX</+C\A$&$%$9X',6.*RYC<BYC G#?R
MX$J_%:)#_-X%:9N_7H760P7OA>%F1U[9FML9!,87FC6"X3HS9IX9].S=SJ&^
M((\BZB!X_0JO?PX>J$F52T6M'UR0N8'!(U*1J2R$43OXC!N9<?&')X3PJB*\
M.H?P@:>,O!39LGE-XAJ>YUT&@T%PA? ,*I[!.3P+^DX>8\@YON)1.6P(':[8
M[UUZ_8%WW<?PKBN\ZW/P)G&\SY/#!7F"]\AGT3B+N&(8>&0.52N!+!#K4FRR
M8:)@"*WOU2;K?1/OU+8@\Q9R*QK-%Y>[8ZD" [YE-$HPOJ,BX'\37[4T9DIN
MN(@:![1%$UT7?ET9?-38OT*;26UH2O[B^<GUVJ+8[89A#V.KJX*/^WHYC1/8
M#)U&P05Z?1\#J2N#CQOZDXQ@3&:)%)A]M(CT@OYE"'\845T0?-S)ORAN#!,P
M,%E6B(-YZ$8J7&A%4XTNPKH(^+A1SV7*(VZX6)-G2&_%:=K(@ZNT\M26[^-^
M/5/L,H+A8;"^]IL+)F+8!GU>K4[,'Z[72E:;OX][]5=DCUH70-8*B,NV M;V
M[^-NO> &"J5<$3_X<?D3F;.H@'S;-3+A2C8_H:K-C8S>+DA.%=G0M&#D^X[G
M^22'WNJ$*HPZJ*M @-OV0M'89M]\ERUE8^ZU",SN%W.,I/;[X"R_O\^86ENB
M7T"A+'U93D7C,+8(MDUM<'02.,OOIY!V"CSM$3+NG7QBS5"X%&R(?"_T_*Z'
MD=5N'^!F/8&E$)?+X2&EZT8>7*!UD&J_#W"K_DAXV"E'"15K=G*_W2+T,IG?
M37YO8G*/SI3V?/Y,;:IHDK(5*'F=*[!MM3_R[AM&YN4Q<RD-'%K+RX11\ O[
M CQ?26D^&O;D6OWP,/X/4$L#!!0    ( %U4U%:?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M 5!+ 0(4 Q0    ( %U4U%8'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 75345L&@IR'O    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ 75345IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " !=5-161JGF%T8$  "$$   &
M        @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ 75345I^@&_"Q @  X@P   T              ( !B@P  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " !=5-16EXJ[',     3 @  "P
M@ %F#P  7W)E;',O+G)E;'-02P$"% ,4    " !=5-16JL0B%C,!   B @
M#P              @ %/$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
M75345B0>FZ*M    ^ $  !H              ( !KQ$  'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 75345F60>9(9 0  SP,  !,
M             ( !E!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  WA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="pets-20230615.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="pets-20230615.htm">pets-20230615.htm</File>
    <File>a8k06152023-ex101.htm</File>
    <File>a8k06152023-ex102.htm</File>
    <File>a8k06152023-ex105.htm</File>
    <File>a8k06152023-ex106.htm</File>
    <File>a8k06152023-ex107.htm</File>
    <File>a8k061523-ex103.htm</File>
    <File>a8k061523-ex104.htm</File>
    <File>pets-20230615.xsd</File>
    <File>pets-20230615_lab.xml</File>
    <File>pets-20230615_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pets-20230615.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "pets-20230615.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pets-20230615_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pets-20230615_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pets-20230615.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "pets",
   "nsuri": "http://www.1800petmeds.com/20230615",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230615.htm",
      "contextRef": "i9365390939e54ea8b43dd533fbda674c_D20230516-20230516",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.1800petmeds.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pets-20230615.htm",
      "contextRef": "i9365390939e54ea8b43dd533fbda674c_D20230516-20230516",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001040130-23-000040-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001040130-23-000040-xbrl.zip
M4$L#!!0    ( %U4U%8:4*H+#R8  $_4   5    83AK,#8Q-3(P,C,M97@Q
M,#$N:'1M[5U9<QM'DG[?7]$K[]AD1!/FI5OC")J";<Y*E):DUNNGB4)W@2BK
MT0WW01+^]9M7'7V ARQ;H*R)F1$!=->9F97'EUDO9O4\^^[%3*OTN_]X\9];
M6]'+(FGF.J^CI-2JUFG45"8_CWY.=?4^VMJ2IPZ+Q;(TY[,ZVMW>W8M^+LKW
MYD+Q[[6I,_V=;>?%M_SYQ;?4R8M)D2Z_>Y&:B\BD_WQ@]A[O/DT?[Z<[J7ZZ
M/YGNJ>W'C_;2W>TD4<G3QP_3?^\\@%?A<7ZGJI>9_N>#N<FW9AK[?_9X=U$_
MOS1I/7NVL[W]CP?TW'<OID5>0V<EO,Q_<AN]EA8J36%^6YF>UL_V'FU#8[6^
MJK=49L[S9[\V56VFRP?<GGTG*;*B?/;5-OWG.?ZR-55SDRV??7-FYKJ*CO5E
M=%+,5?Y-7*F\VJIT::;\8&5^US!0Z(8^7O(D]J&=S.3:3HIG$D5V\']N[X]7
M]#Z^FIF)J:.=[=%.>QF#!0Q6*X'MUN6#E8N_9F_]U0OZ=GSV>OPR&O_?VY/Q
MZ6D<'1T?CM9^T,#>N]'X]=M7;WX9CZ/Q_[P[.OLE.GSS^NWX^/3@[.C-<?3V
MU<'QO=^Q80;<4"#!4#Q$*D^C4E>UJO%3/=/16UV_!NDXOEK ]Q7L9IZ,HK6?
M$6_G?)$52ZVC\6^-J9<@S.<+G5<PMR*/3F"6I4E0\I_61?(^>INI?+,WL4\S
M_*^_VGFT_7SE*L]5>0XGPZ2HZV).;7XBKMD916_?G;Q]<SJ.WOQP:PZ1TX8/
M().G0"C/=I[\!9,87NPSH/)%4RZ*2D?%=#71WTQ32$+1].NO]A\_?T__KZBU
M#R3&: -?_OJKO?WGU )^1Y\VX^AR9I)99*IHHI%1D6,GF:EFT,!D.3Q\Z&:B
M9RJ;XB1-7>EL&N._4=5,*I,:51I84Q0 :CHUF0&EJ(HV8!,RG=3F0F?+.'(#
MPM&K?&F' P.IBZC225-JD2&U,GFD9=(5]EDT-0Q3Y,P$>H!5P&?AS4597)@4
M7@4E!1=$9=&\@$YY=;#I!J;K6X-O])4N:QR0*6%>51WIZ;0H83JM>>* 9:RC
MZ,Q_@-<7,"UH::9J6(7HTF09O)?K*7R8EL6<7H7QP#HFQ7QN:E(6>=T[HZ%W
M9^I"1S!E?.T2UE:5NC. 2,'RHG1MLEI^@K$7E[DNJYE91$4)[Z,V6D&?P=>M
M1KZI\*\Y3)((Y58'ZZ?5[NZ++-L=1:=G;P[_.SI]]_V_QH=GT=F;Z.RG,7,O
MBK:OOWKX]'ET]LO;\2E*NX.?#TY>GMY3>5?-@#Z%^N=J"90?J4M5(K4W,,#2
MRRV61)>FG@'_1@NU)#X (;-096T2 T195YO8(#$0O9@PA59(H3$^&%VHK-'1
M?XVVMW>B!31/_<==!MGX^JLGN[O;ST,*IZ]V4,B@K'#=J 8&5,*LTSB:P,":
M?,M458,?>6[,[G-U9>;-/,J;^02ZA?YDYO!7V,O@2LQTJ7DU-D!&_@KR @4/
M<7**>XHK42%7B_@"V:NSXM(N1E[45B"H\_-2GX-$!;F3:'AP)X8]QO^YT9X.
MCPMDVE0;/!@ZTD.%&P!2 70ML!998,+/+)UHKT"N%#"($K8E9_%:V86GF=)
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MO'P:=6Q_%(U?'?UX]/W1JZ.S7[Z<MG_:P ^ ]5WH+908Q70*VCYJ?IVH BB
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M2:8ZR10ZQA%@A:_(D/MZM=7:W&@NP(")-N#47H"9Q X<Q'&5Q=5RL]46>DO
MQ+#^DK8]@("LG<?/JW M84-O4'4\VFA0U\&Q6HP9K:;5#PA:55EGVJD88 \W
MDDV"9Q73^,.6J[?#UE!)-3D^* 90LUT$MD)Q2>XN&!FTEH'UI070E48J25!]
MYCF AC%IRLI%EL38D@':50DIGTBV2)(&+(H<6G;*CFAO2[MZJZ D10A*]5V1
MHT<L([$B](4-,WY06Z37.SQ:W)V)HXM>!.^&11'H;0AU$\KUA@DMB'O#;1;8
M<$V9LRX<FJR?KZ!?/Z3(&=JF,2Q]2Y$_"13Y4734#L$2 3"(HN:WO1D0MVP
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M7.7F][!Z>0F436-G(D3S%5;1 'NDEF0+2Z&J@G.5:A;HK;2XM%]C^4LB\8Q
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MQMUGD@.:LP4BD?9V]SN02CDF*J0WK-AY"5J?J_K9<VV&,C@X8B>@W>:6<D*
MA12K( SK49X@*(2R(:1Y>V>;B*>$T((;G2B1U/^8$2I2U;--%%X('ZU-314,
MZPAA:W6GKC7V+-512TG%%N1+:W8D')L$:W47_0J(3F-RIHHKB$J+)8>I\E_+
M6;ER108$\81RK/O+@X99NPCKQL$F]1E4=O33G"Q)4;+78R#'(_N[ &I1^L.7
M FT7* .FL5_ ^K+8 DJ1"B=L$=BEPNG"-WF$GEG.8X.!#.RIQ=^J1 "WMGJ4
M\7%@ZS8%H6<K-3T&=1RI5:RA[S?=XK:AL,H6I<(!H3)#MP<'59B\/NMF:ZD7
M04%D]T$KE&LO.7LI0AW-I"5][8!,/SWG'O'_O99< B5SLJ?BF&E*10; MC>I
M<MGZ$MRU=""T'DOM>2P$A-6SR@X<7HJ_D7J.X=V*H#$J]Q%""?OQ%T!4#@D=
M2D+R7LI9'I"5K\'S!(]+08UQR&=17/HBSLA76ZW A#_;K?A8,9C;C ,6#HO8
M]^^8!'8:#F%U+H\=$OO=7NZEAOT1V&-=*@@'E;-"CQ[?88PBLAJ0D(SC$3)S
M7UL,URV*B]-E'7+?*,8$C(,V\@6D+KK5<5<,87DHYE+Y$MWAS:2=:TSI'FEK
M>:="]V1_LX> *H:T+E#F-6",&,H'&P>][5+01.7<LF6A[(21?6-?CV_E5'F"
MP6E#F/QXR'FSTEXK-?RLY)YM;[U9U FA2Z?]R=9AS8K>Y&\U2[LMX?TC06&<
MG.IK.97$%2547H39T>&2^!I^_4)J%"M=^B,\<'N0^53J"U,T579M*^P.N08E
M2:1"1:W;#E=2@.53;V&'G0NK82!_1()\YC>TKA_ Y&<@-CP/X8?V'?"=JYH<
M:B'%NVSD%G@'/!("?X]7%J6-2S(+I9=+@L/??=)*6')LDYV44YTR(I,"$PSC
MPKPI1I*&7;6P31X8Y0,HF;H48P.9BA2"(=0ME<&*;4P^;D.^PEKTGW%@8/WJ
MFAUXP$68,G)D-3HGR/NW;H54-0#S$1]W6&J3#E+?8:^P5]]/WBZ\3W<KU8/X
M(3S-6C#/H1K]:Z0)?AJ P)-1]/KH]'#\ZM7!\?C-N]5X@/NI2.^-'MY& -!C
MGPZH@"4F3ZRD/Q'@SP%?PG)<H$/MO']UCM.'R#]5-JP0G1O!#ZZX.<=C"UOW
MF5YSZ<=MK:T/6.KKU8Z_.8;H_A'R9#,Z($S_G$&Q1U.7H]=6;\2_R3<M8?;)
M19%=2/A.P.K>^=!R+^1!Q/$:2"K'*$A3L:'=-+:XA^YHJF;"$#M\G#-!]'4=
MB '3;D1JNMMR_@ZT%T=][Y+<BF/=@ZWZ^AT4*LTV1M- ^3RB:*(J@[?)7B5:
M(T!54_G\A+ N.]O_<'&;P:N9[=W%-M)*Y?E#X**I7(7Z>'BR=NA."73ONEUK
MX3M$=E$Y"$G[D\NF2[UH2M@@SMRW(%D7!A[P"@19')-E:#0:J7NF,M[V((>!
MD)8*D9X\'T56??MJ3<&HA-3FAF%GCTD>\)OF*@2+9I*9)".[$V>2J(6I@3E_
M=XE+SE>H9!F0SFWB D_6Y6CPA:1N11D5RLM-IG=L:4$6,Y$U(\\V[%:#X0QH
MPSU@4REZJ&&Y+M34E$J'HM\Q+:4UE-QW:F1A<37S# /R PFDI/0M"L29XLJ[
M;S&C+$]=T($OO+Q0)B-(ASUF>MG&>9_:.)&TH=M.*1&(5#[2)PDVAG:'J['Q
MZ08OV4PV=X.\O3Z=5W*4R;$AZ6O]&N#M)J4?&R/8987Z5@V%_EU[?9KSJ?0@
M%:&A157Q\Z6[^&-0C:?\M@W.Z<V,;GK^-;E,V-V3(57EVS?+LPTH&18\AMZX
MJ:"NC3A;U%F"8\\RGZW'[G80D)B;&%PA1RULV"L\Z%6^KM4^T>J<'M^T>"66
MP$[8].NH?C*UZ';-?ZK+Y58C+-W1T(XXA/SN,BLP^!8 6TG ML_5"$V\HK2R
MU[I?^:%JD5$6?Y#6R<>E)(@%1TU;1,,7+E?.!WYLMIR'?/72;FXJBNWOWD9<
M/GI8FHJO2AQ(8FC7L2:$DRK]SURGI'6Q3*"MN#7LXE8+T/KQQN2;7"H?6)OD
M_JFK"=E=8]9E@$S'/@C "5_7&%\L_/"[%?>0._]6*%UZ56,$*2$'6]>6HQQ4
M^PR8&H%'<""%WF?+\Q6'K@QUP$G?5&&H(U##B9><[>A3= ,F)'.1;LYP'NMV
MSN*7.Q __SL0AZHKK^3\M6#S(7?1'6Y0_.!Y#IGX?VJ1ZQL$,%_J> _VY2[5
M:->-V#9 @?S10=!?J<M1A'>#MR^,N]&-MP+%S#CX:?0#S 74$IMM(L>[Y/HM
MT#V_$ "3A'3PS3]175T'RKG/\\&[JXZ+5I( _/>P*,&>P?/[P-U#Q,I([P*Q
MFWS"UBCN:@QDYSF=@2]KY *-7!/%#B!TAY!SB& "_8(%G#+4TD(FNG6ABU>;
M)GPIEBT[8Z.47)Y3, /BF/&9U^2K .ZJ;-D'&S/OU5U888-<<_$.W?/D$]6P
MPH53?2PT,?:0YC* 1PE*,-#T:?VPI$6DJ&C'36O?L6*<!7X3WFEM[+ZUBFD]
M'47C'WX8'YX=_>\X>GEP-L8RA;S1KPZ.[^UBKA[GN@##SCJLR 8G ?D2RD=W
MF9# +O]JX(?=)S&](=Y- EO-NJ7KX,M+):'<"R]YJ-K?,*APQ$L8G;4]:H;=
MG0A5GMLT4I0_-A%3&@D&3B@E-*;=C;#,ERN;H('*2Q3<[@SZ9IP;+4VNHW_#
M?VAQ]KX$K@<&L[,-NM7K\?%+^-\U)46_,/7'+>5%_M^YA'J\CZ%]"%N7:^4Y
MU*<!2';EX&^FC2,*8$FD7Q P"<%%%%NQR9\V1L6)H<!-..)C5:7J-SGV7U,(
MS &M6AF=KNA."V[%4VS/2DJ!W5M2NT?>F-W1SO;'OYOCT>CA+2_1N-/='$]@
MEK>[\N/O>#>'^MQNYKCI*N(GB(/HI]":/"DIYPR_GZLK,V_F0>EBY[VG2HE\
M#_/*A-QV=N/]OPGDBV3Z(ID^94V.ST8RU59K29OV%8-MT7&W"\"^2(\OTN.+
M]%B=4_*92(^YHJK6Z/5HZ2H.%47E<.5>E%9FUK6@X?LO7];?1$?4C7=)$?RL
MMLGO_:IE[%.;+Y0I@XK<+L4GS![JY\0-8;2DRH]S[HF%/UR7S4*P.-S0R5;"
M6\$F'-RXB]/[P]+:UG<_^RX7+H<>>]<+@^"X3#7MPC6A#7M)05!?(HZ\&>-A
M3?H*"^Q57(_+F3:] $N0?>.K*!&.!4<9%.[W-$FQHR](_V&D_]H(P. (2 W,
MSU0SW1,1;89=01X]C*9%0/DLWB 6@$>.9$(SYG;9E0Q\N4@7QJRYO""+C-:X
MG)21\824&;=EY<JAJDKN!9'+0+ B2CO8WAX/)YR%H4L&6DLH%*LJ9%*QF]BV
M5>'.+EQFN$"QN$%;>9Y2MGZX=)U<<X%0_R+,DI"P@JO/*(X&Q>5T<@2\ Y]+
M??WO;S/#UJP6XK&(INJB*-TMC5)H'R>EKJ /K6J?U&E%EMT<-T0+A3^\:1@N
M!<!7L;3U50K-QU% RYQD2'%CJEQ!D6-LTN=$V#VWZ0%ADZ8:#%H[F#&UAS&B
M,.VVE2/+ >*-BNI,SQG(E[N0MFV0(OQ('NY\;8&J79'% )0<%"'LP)/C((CL
MJ-TQ'R':.=N&H8<T::X^+E=MY@Z!W<+"<ZU1/KT/BU0[?/K^]M.#@0NGI8 2
M770A352%M,+9)<6U789<T^^OTWAEG[^_$?-/.,X5<;:=4?3RW<G!V=&;8[K4
M#^M)'QW3YW4:_6>FTG<BUYT*H(1^Y^JZT;0I.96:<["E;K)5!SWBF#29. R[
M[^UROH>KY=)/]5@5X0LS^*1 )O94%QQDZUSM6@]-!H1T',WLG1!MJ6Q2JJQ6
MKKQ?T!\B""["LO8#,PZJQKFB&GY@UUVILN[T^XE$ =#+X9O7;U\=T8V>/Q^=
M_12=(LP&),/.(U0>4#X<OGDY=E^CE%ZG51Z>V#V6$KH-;UEU=%+6K5<XV\S$
M]3<?3;;VK$[S(]_.1K\P^YT$M98'ZY7?5!B4D;!!>F75R8?T]<! .["W=4]!
M:4=X3^>^#RE39B=!ESV!,. :U%-_0>6L-55LQ)NX>,46R =8G*X1PY<"^^RU
M'F;7(B%1]RA%$5:^I\Z:>IP![@"7!NS/L%M]F\9PHVGO53IGL9,=P.I=*VL2
ME6!1;/E6%[K[1RHH4KZ>M^L#+2^6K&A+2E+&LX5H;NED,I$CU&HQW>A$+@$D
M[8T(X\FCD#"B#2G:V5/O;,E.NLX9S M#]Y;CK*?*9)C-VZJFV'L_2'IL#;>O
M1](U1KE#O$IEOR[\([1(O!%D2XC*73!"&@&QKE!;:47IU,1EE;MAPI"OTX=O
MTR:G@PU6Y.\<QF&M,W>W(C"F.<>\-S&\72VTUM5E075>N>C6I>RVO8:#]<2"
M*FK#8Z#2+J@JP'=(E$(7E<;@NK_?0!X7ZHB&:PKW%JAO707VF6/U(7^&WX?"
M2A3B>IN!U_5@*C=PN>$W;=W_>(<Q!Q73K0+S9RT/;V7<H?+P]@UF0$IYF[?N
M&PS*]U"I**:206Y<.M(B$35TP[N_/<+6<ELQP4"N6HM6%#[%J^78QEQQ(>)*
MJO>U%$+,G!SNX#H%<3T\EM].BG0)_\SJ>?;=_P-02P,$%     @ 75345HS/
M9W1&+P  ;WH! !4   !A.&LP-C$U,C R,RUE>#$P,BYH=&WM?>E7&\>V[_?W
M5_1S[DE@+:$@)H/MX[4(EA/NLS$/R,D]G[)*W254<:M;Z0'0^>OO'JJJJP<)
M@<'=V&0E :0>:MA[UQY_^\TDFX9OWTRD"-[^GS?_=V/#>Q?[^51&F><G4F0R
M\/)419?>'X%,/WL;&_JJHW@V3]3E)/.V-K>VO3_BY+.Z$OQ]IK)0OC7/>?,S
M__WF9WK)FU$<S-^^"=25IX)_OE!RYV!_)]@9[/JC\<[!WI[8&07C[=V]S<'6
M]GA_]^#/P0NX%2[G>])L'LI_OIBJ:&,B\?VO7F[-LM?7*L@FKP:;F_]X0=>]
M?3..HPQ>EL#-_"L_H_:DF0@"F-]&*,?9J^V]37A8)F^R#1&JR^C57WF:J?'\
M!3_/W./'89R\^F&3_GF-WVR,Q52%\U<_7:BI3+T3>>V=Q5,1_=1+191NI#)1
M8[XP5?^1,%!X#?UYK2<!SPE5),VD>";#FXD:J<P;;/:WRM-P)N",UH?EELF+
MA9-_M+L>;V%V&A?F='CQ<?C.&_[/Z=GP_+SG'9\<]3L_:&"4+6_X\?3#IW\/
MA][P__]^?/%O[^C3Q]/AR?GAQ?&GDR^=P7C\J#-@O@BD'R<B4W'TBB[()DF<
M7TY>O(6=N#@[/KJ ?3F_^'3T_SPSG3;6VCO]<'CW]7PPXA^/O]XNY%$@$[SJ
MQ=LU 0(7I9DGHL!+9)K!)?!7-I'>J<P^@C ?WLS@\Q18)O+[WA.>*W/3=!;&
M<RF]X=^YRN9P*DUG,DKI8N\,YI\H'X^P\RSV/WNGH8C6:U-NAT!__&&PM_EZ
MX?I/17()1]PHSK)X2L]L26@-^M[I[V>GG\Z'WJ?W*W.5/C9Y_Q1L6@3/VV]M
M$A= _[,\F<6I].+Q8G8@FKI%;+5$[DLI'0G;&__XP\[+UY_I_X+F>#N+M"FB
M&]G36\.!__C#]LYK&CU^1G^M][SKB?(GGDJ]D42AAM)M%*IT @\8S9LW%*8X
MDA,1CG';59;*<-S#GUZ:CU(5*)$HF! *2S$>JU"!OIMZ:[ "H?0S=27#><^S
M \*5$]'<# <&DL5>*OT\D5K>9D)%GM0+GN([XSR#86J9/((WP [@M7#G+(FO
M5 "W@OZ)FR%";QK#2WEG\-$Y3+=X&GPB;V22X8!4 O-*,T^.QW$"TRG-$P>L
MQ]KW+HH_X/893 N>-!$9K()WK<(0[HOD&/X8)_&4;H7QP#KZ\72J,K(#>-TK
MHZ%[)^)*>C!EO.T:UE8DLC( 3\#RXDF4AYG^"L8>7T<R22=JYL4)W(^&1@KO
M=#XN/>2G%'^;PB2)4%;2]+Z6XOZTI?M67^MJY[__\M_#HPOOXI-W\=N0)8<K
M[+LE#'_\8??@M7?Q[]/A.9Y*AW\<GKT[?Z+G4CH!KM$\.15SX$=/7(L$>9!F
M7$AREH_7*IN 5/%F8D[<":)O)I),^0I8)4O7\8'$UG2CSWR3(M_T\$+O2H2Y
M]/ZKO[DY\&;P>'I_K\JV:S_^L+^UM?G:Y3OZ:("B#R68?8W(84 )S#KH>2,8
M6!YMJ#3-\4^>&PNAJ;A1TWSJ1?ET!*^%]^F9PV_N6QI78B(3R:NQ!I+[+Y!B
M* Y)O@2XI[@2*<H:+53A1)!A?&T6(XHS(Z;$Y64B+T'.@S3T)5PXZ,$>XW]V
MM.?-XP)).Y8*CZN*3!/N!H"L FUYJB(6X_ URTS:JVYR$\C@&)8F 6*)^"A*
M#3G0^M/R\9D[E;=.XE$9AK=37.(Y.X+)3&&(5T*%H A(W" ]X ;&N<NAL4@\
MK&P>WEW,M+3UR)ACT';B:S(3YS.F>UK%U##A90)TW2R.0!#O+S[F'FIEZ\?E
MZY+7#A_4X+0KO6RCD^N_)M9;E FE1=SK'PS,,C8/MJJP&XU\*F$(2Z4YZH6N
MW/82E7[&2[5,10T:F#?1+V )!/(:""\=RZ2'7\+N3YKO-+Z.YEOU&(&40S$#
M^R^?Q9$Y&F>A-%):X&&HXH .)IE<*9^&A'92.A:^N:PF*->*YX,B&^8!G[O"
MGRAY)4GJPVWP;!@P[!<\]3(685JU7O39"RIW)N7Z8F'U#;/"J$.LL+US-U;P
M?H_ JBPS!&XI1TB Y!/I2[ G@<R(3YJ4"T\"T=2=5OAD8@#A^2*=6+T/'\^Z
M'#S+FL;R[QSL2'@A?CT68&L!Q7R&4]M>&D>R>0P]5)%H#/ >S2</Q"-5G6TV
M"Y5/9W8@@4D3&+(DBYM8TU'_K&KI\ CJI]\GA_@=XI#;#HM31^(],(LT/[HU
M'KE5U#\&^7L+5H&5-LM[=UOAE0]&6 3CM3+K>-LJW(5A6[+&M_O>X;N/QR?'
MYQ=G*\?C.NA1*)P%A8T>@$6J4K!,R[1D'<%6]S"6WR\Q&E+PQSL%9)/%"; N
M$3YQ4CQ%1A+L%XWB:,,X!KU 7T[?H*4,) ZC#)!FSG(@^<'>:&/;O.57&4DD
M?_R&_;!G\C(/!9\;A<%QCEY6H#>X:'CC3T1T*;U#GRAM<+"]TR.3'&-?\*+"
M@VPGQ2[;OG<2@^ Q[H>2RE4LE81M5<B;Z*(U=GUFW9SW,BB[Z87L-A57MX9\
MS;@#:1Q:T9C-<9O6U/HRKT2[87'V2"RPCHR;K:KU&5=;-QU&4_%9>P4<;T&K
MT?YFU\3!:R -H TX#E,4?AC+4&!%EJ[K@81BCQV35V<)B5R;J>N=,Z[CV'&5
M<KRJ9 ZC6&6=O,T]PC7FL3B606<7V]'1LKB;7!B/6V4Y4@:(Z#J[B4Z089&
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M*U/R@U9=INP4K8=Z264.2C4$C@^VQ^$N[M:=&:0'2AFA_=+0V#JD[*2[%5@
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M<(Q<]@+M;BH_!)8DI#[V&OW05&WVO'K@1C<E-E%2*M*U59[E,F2:;0]=)J*
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M?$H]0 \V'[[A[_96?W__X9N XF@'BV^]1Q/0+V@SOE!*=T(D-\5*5V@,:II
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M!_R3T2VIVU7*>T]$!_LC,7X].3N!_RY_ V_M72*:R(A:6=]4Z,*1B@UGMYB
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MX>=N=AEA3ZFFG5=#8+@!T9-6G)>-/D:#Q&*T%'($@*:V+8X^2A.!B^)YK_\
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MML/K7:%8QQ3>UN]P#NS2-/E*\2+MMH-J"[G+S>R0@<PTR Q,,%=8UZAH6'R
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MF 2@B.0L4VY,G=RXR4!G#Q,("0.8;DR!.2M";1,+.FR<E+3#&RXF<.>#>7=
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M"6FAJT$_F+J5F1$DCU@S22'4PB ),Z>JSH+14OEY7E?WI="27%\9\X=;Y;(
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M8YI=O)\6QVRZ7^YNTB^&_P=02P,$%     @ 75345J_>@X94#@  .40  !,
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MD"F/X#K+M)K*4(0 JY3Q - 7\C00[$[:"6U"-QA:ZFDHQ=VL/ 6NW4UD,&%
M+6Q5H!B."_JB102/Q&W=HYL.LD!6-EO:%75P+) ?!6W%>:K\Q(V0Q@T'V_G%
M!S!I +BW%U<#DA&($C1?. M1,"]26MPHY!DR%G])<IOS&% &MUI^"Y<*N>,.
MEL/C0B>_#+DJW%6$+]I$1$D$5D3=F>?/]@Z.-I;)W3;[02.>@)%7<Q4=DHJ^
M1Q5M,S#1*S6C!'X=OBB!!46,<@W_TVY%LZ:-<'-A&NB'4C@H:_)"I9.J6QP4
M%ZC6#5)O5FE(X9#66)ZY^5Y];F?+FTQP4.I2NTM[959;*Y5ZB[5@L%XLFBI
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M/H>F3I2F4:^FE!6[GT*+I$^ W9QX [H6G\4(HW&VOJ;$"5C>C1/% +OL1D%
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M+5=5A<J69U<]UZPH5K52VK+E_\QZ%V^,G4"L#W=;'>EP]Z!]V%EY(3X8Q,F
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M@R'X62QB%5LQYQS:-3ZK2Y?6L#:SLLE7LO/&/C_%I8^GN&#5ELC1:(ZLW?,
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M25%!T>_P%%P%M/CBW!Y!UD$B4HV4B9!#'/\S+;4Y];VI_0H.2Z\9$]2?:\:
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M07'5DD$/:](V5^APQVI940L^QE%>BBTJ//(ZG)<X;'&%F'&-?A$'5<_^/\?
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M^?7D'O(&D9*&;IKC>8>P7J7U0E^_?K^BX8+MOQ\MH1/L-WLQ^@-02P,$%
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MKK/MIW2NUHFAGDLE3?P("!(R@'DL :%2 NF+A"(<!8I2NTGVR?C8I+>>,2J
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M^\/BL^%!4)CO!(H7ZCDE)/J\Z'U]65>?\C)@6N29D Q/U=I:(#)Z2ASW@F3
MG4+)O!)Z?UQ\97T0'/8[@6.,LE,BY+)J6E?\F6_[M%G3[GA-/8D)#)$J K'
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M,2YH=&U02P$"% ,4    " !=5-16C,]G=$8O  !O>@$ %0
M@ %")@  83AK,#8Q-3(P,C,M97@Q,#(N:'1M4$L! A0#%     @ 75345L93
MB?BQ'P  J90  !4              ( !NU4  &$X:S V,34R,#(S+65X,3 U
M+FAT;5!+ 0(4 Q0    ( %U4U%:#'&U%S2D  (I% 0 5              "
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M-C$U7VQA8BYX;6Q02P$"% ,4    " !=5-16Y0HH=Z\&  #D,   %0
M        @ $1]   <&5T<RTR,#(S,#8Q-5]P<F4N>&UL4$L%!@     +  L
*U0(  //Z      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
